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Apoptosis is a form of programmed cell death that is necessary for development and organism 
homeostasis.  The early stages of apoptosis are marked by the permeabilization of the 
mitochondrial outer membrane, the release of cytochrome c and Smac from mitochondria, and 
the activation of the caspase family of proteases.  The permeabilization of the mitochondria outer 
membrane is thought to represent the commitment of a cell to an apoptotic fate, and the 
subsequent release of mitochondrial proteins is an “all or none” phenomenon that is completed in 
an individual cell within minutes.  Although the cellular decision to commit to apoptosis is 
important for organism homeostasis, there is considerable variability in the onset of apoptosis 
between cells in culture, even in clonal populations.  Here we developed a reporter (pmDEVD) 
for caspase activation in single cells.  The pmDEVD reporter relocalizes from the plasma 
membrane to the cytoplasm after caspase activation.  We find that the reporter has similar kinetic 
properties but better fold-increase properties than existing reporters.  Using the pmDEVD 
reporter in single cells, we observe that the onset of caspase activity was tightly synchronized 
between nearby cells. This synchrony was not a consequence of secreted factors and was not 
correlated to the cell cycle.  A similarity of apoptosis times was seen amongst sister and related 
cells and was lost over successive generations. The times of apoptosis also diverged within a 
generation, but this was blocked by inhibiting protein synthesis before triggering apoptosis. 
These results suggest that the cell-cell variability of apoptosis times is due to the divergence of 
the molecular composition of the cell, and that the decision to commit to apoptosis at the time of 
drug addition has a deterministic component.  We used the deterministic nature of apoptosis in 
single cells to monitor the release of mitochondrial release at a rapid temporal resolution.  At a 
rapid time resolution, we find that the release of cytochrome c propagates throughout the cell as 
a spatially coordinated wave. The permeability of the outer membrane to Smac propagates with 
the same spatial pattern as cytochrome c but lagging in time. This is followed by a wave of 
increased permeability of the inner membrane to protons. Only afterward do the mitochondria 
fission. The spatial dependence of the permeability wave was inhibited by thapsigargin, an 
inhibitor of the endoplasmic reticulum calcium pumps, but buffering cytosolic calcium had no 
effect. Altogether, these results demonstrate the organized dynamics of apoptosis.  First the onset 
of apoptosis in a single cell has a deterministic component, and second, the trigger for apoptosis 
is spatially localized, initiating at one or only a few mitochondria and then propagating across the 
cell. 
 
iii 
 
 
 
 
 
 
 
To Peter, Jenifer, Priya, 
Sarah and Lana 
 
iv 
 
Acknowledgements 
 
I thank Dr. Sandy Simon for being a wonderful teacher and advisor during the 
past 5 years.  I have appreciated and copied his views on the importance of observation in 
science, and the belief that there are many hidden biological processes waiting to be 
found. 
I thank Dr. Alexa Mattheyses for being a wonderful collaborator.  I deeply 
appreciate the propagated knowledge on imaging and quantification, as well as our many 
stimulating discussions. 
I thank Dr. Marina Fix for being so supportive and helpful since the very 
beginning.  I learned basic lab work from Marina including cloning, and cell culture, and 
I am very grateful for this. 
I thank Shahrnaz Kemal for helping me integrate into the lab, as well as for 
helping me find things. 
Dr. Shai Shaham and Dr. Hermann Steller for their guidance during the faculty 
advisory committees, and for the courses they taught and their stimulating discussions. 
Dr. Richard Youle, the external member of the thesis committee.  I am honored to 
have Dr. Youle given his contributions to the cell biology of apoptosis. 
v 
 
I thank the members of the Simon Lab for a lot of advice and technical help, and 
for the very active and stimulating lab meetings. 
Finally, I appreciate the many reagents received from Roger Tsien, David Piston, 
Hermann Steller, Richard Youle, Junying Yuan, Douglas Green, Micheal Lenardo, Paul 
Greengard and Patrick Daugherty. 
vi 
 
Table of Contents 
 
Dedication           iii 
Acknowledgements          iv 
Table of Contents          vi 
List of Figures           x 
List of Tables           xiv 
List of Abbreviations          xv 
Chapter One: Introduction         1 
 Early Observations of Cell Death       1 
 Molecular Components of Apoptosis Signaling     4 
 Genetically Encoded Fluorescent Proteins      31 
 Genetically Encoded Caspase Reporters      27 
 Variability in Commitment to Apoptosis       35 
Chapter Two: Design and Characterization of the Caspase Reporter   38 
vii 
 
 Introduction          38 
 Results          39 
  Reporter Design and Measurement      39 
  Comparison to Existing Reporters       48 
  Effect on the Progression of Apoptosis      58 
 Summary          59 
Chapter Three: Similarity of Sister Cell Apoptosis      61 
 Introduction          61 
 Results          62 
Neighboring Apoptosis       62 
  Correlation Between Apoptosis and the Cell Cycle    67 
  Separation of Distance and Genealogy     75 
  Similarity of Sister Cell Apoptosis      83 
  Intergenerational Divergence of Apoptosis Susceptibility   87 
  Intragenerational Divergence of Apoptosis Susceptibility   93 
viii 
 
  Inhibition of Apoptosis Divergence Time     94 
 Summary          97 
Chapter Four: Spatial and Temporal Release of Cytochrome c    100 
 Introduction          100 
 Results          102 
  Waves of Cytochrome c Release in Single Cells    102 
  Quantification of Cytochrome c Release Waves    105 
  Patterns of Cytochrome c Release      110 
Dynamics of ∆Ψ Loss and Cytochrome c Release    114 
Dynamics of Cytochrome c and Smac Release    118 
Mitochondrial Fission        121 
Release of Cytochrome c From Individual Mitochondria   126 
Inhibition of Cytochrome c Release Waves     128 
 Summary          129 
Chapter Five: Conclusions and Future Directions      132 
ix 
 
Chapter Six: Materials and Methods        150 
x 
 
List of Figures 
 
Figure 1: Mitochondrial Proteins during apoptosis      9 
Figure 2: Existing reporters for protease activity in living cells    33 
Figure 3: Design of the pmDEVD Reporter       41 
Figure 4: Design of the erDEVD Reporter       42 
Figure 5: Time lapse images and quantification of the pmDEVD reporter   44 
Figure 6: Time lapse images and quantification of the pmDEVD reporter using 
widefield microscopy         46 
Figure 7: Time lapse images and quantification of the erDEVD reporter   47 
Figure 8: Comparison of the fold increase of the caspase reporters    49 
Figure 9: Comparison of the signal to noise ratio of the caspase reporters   51 
Figure 10: Comparison of the kinetics of the different reporters in the same cell  53 
Figure 11: Quantification of reporter kinetics      55 
Figure 12: Cytochrome c-GFP and pmDEVD-mCherry activity in the same cell  57 
xi 
 
Figure 13: Effect of the pmDEVD reporter on the kinetics of TUNEL staining  59 
Figure 14: Local synchrony of apoptosis       65 
Figure 15: Correlation between distance and caspase activation time for pairs of  
HeLa cell          66 
Figure 16: Apoptosis time as a function of release from a double thymidine block  68 
Figure 17: Images of PSLD-mCitrine during the cell cycle     69 
Figure 18: Quantification of the PSLD-mCitrine reporter     71 
Figure 19: Expression of the PSLD-mCitrine reporter and the pmDEVD reporter  
in the same cell         72 
Figure 20: Correlation of the cell cycle stage and the time to caspase activation  74 
Figure 21: Distance between HeLa or HT1080 sister cells     76 
Figure 22: Example of an interloper cell between a sister cell pair, and their  
apoptotic fates          78 
Figure 23: Correlation between distance and apoptosis time for pairs of HT1080 cells 79 
Figure 24: Overview of cells plated at various times prior to apoptosis   80 
xii 
 
Figure 25: Correlation between distance and apoptosis time for cells  
plated at different times prior to apoptosis      81 
Figure 26: Correlation between distance and apoptosis time excluding related cells 83 
Figure 27: Histogram of difference in sister cell apoptosis time for sister cells  84 
Figure 28: Average difference in DEVDase activation between sister cells  
in response to different stimuli in different cell lines.     85 
Figure 29: Apoptotic fates of sister cells       87 
Figure 30: Lineage of cells         89 
Figure 31: Histograms of apoptosis time differences for various relations of cells  90 
Figure 32: Difference in DEVDase activation between cells from different generations 91 
Figure 33: Apoptosis kinetics in clonal populations      92 
Figure 34: Difference in DEVDase activation between related cells    94 
Figure 35: Scheme of protein inhibition experiment      95 
Figure 36: Difference in DEVDase activation between newly divided sister  
cells for different CHX treatments       96 
xiii 
 
Figure 37: Protein inhibition experiment using puromycin     99 
Figure 38: Wave of cytochrome c-GFP release in single cells    104 
Figure 39: Wave of cytochrome c GFP release in confocal microscopy   105 
Figure 40:  Image of Cytochrome c-GFP Regions of Interest    106 
Figure 41: Analysis of cytochrome c release       109 
Figure 42: Spatial patterns of cytochrome c release      113 
Figure 43: Release of cytochrome c and loss of TMRE     117 
Figure 44: Release of cytochrome c and Smac      119 
Figure 45: Quantification of cytochrome c release and Smac release   120 
Figure 46: Mitochondrial fragmentation       123 
Figure 47: Cytochrome c release and mitochondrial fragmentation    124 
Figure 48: Quantification of cytochrome c release and mitochondria fragmentation 125 
Figure 49: Release of cytochrome c using total internal reflection microscopy  127 
Figure 50: Effect of thapsigargin on duration of cell wide cytochrome c release  131 
xiv 
 
List of Tables 
 
Table 1: Bcl-2 Molecules         8 
Table 2: Classification of Apoptotic Caspases       24 
Table 3: Genetically Encoded Fluorescent Proteins      32 
Table 4: Different patterns of cytochrome c release in response to different stimuli 114 
Table 5: Filters Used in Widefield Microscopy      152 
Table 6: Filters Used in Confocal Microscopy      154 
 
xv 
 
List of Abbreviations 
 
FRET – Forster Resonance Energy Transfer 
NES – Nuclear Export Signal 
NLS – Nuclear Localization Signal 
EGTA - ethylene glycol tetraacetic acid 
ROI – Region of Interest 
TNFα – Tumor Necrosis Factor Alpha 
CHX – Cycloheximide 
ETO - Etoposide 
STS - Staurosporine 
SERCA - Sarco/Endoplasmic Reticulum Ca
2+
- ATPase 
∆Ψ – Mitochondrial intermembrane space potential 
EGFP – Enhanced Green Fluorescent Protein 
TMRE – Tetramethyl rhodamine ester 
xvi 
 
GFP – Green Fluorescent Protein 
CFP – Cyan Fluorescent Protein 
YFP – Yellow Fluorescent Protein 
TRAIL – TNF Related Apoptosis Inducing Ligand 
pmDEVD – plasma membrane DEVD reporter 
erDEVD – endoplasmic reticulum DEVD reporter 
pmControl - plasma membrane Control reporter 
erControl - endoplasmic reticulum Control reporter 
DD – death domain 
DED – death effector domain 
PSLD – phosphorylated signal localization domain (from human DNA helicase B) 
ER – endoplasmic reticulum 
CARD – caspase activation recruitment domain 
ANOVA – analysis of variance 
 
1 
 
Chapter1: Introduction 
 
Apoptosis is a form of programmed cell death which eliminates harmful or 
unwanted cells in multi-cellular organisms (Ellis et al., 1991).  Generally, apoptosis is 
important for organism development and in the maintenance of organism homeostasis.  
Below is an overview of some of the early observations of cell death and apoptosis, and 
some of the organelles and molecules involved in apoptosis with an emphasis on aspects 
relevant to this thesis. 
 
Early Observations of Cell Death 
Early reports of cell death date back to at least 1842 with experiments on cell 
death in insect metamorphosis (Clarke and Clarke, 1996).  Over the next decades, studies 
on cell death focused on phagocytosis (the process where one cell engulfs another 
otherwise healthy cell) (Tauber, 2003), and necrosis (the death of injured cells) (Majno 
and Joris, 1995).  Cell death was also observed in various developing organisms, and was 
eventually proposed to play a vital role (and not a detrimental role) in organism 
development (Glucksmann, 1951).  Experimental manipulation of cell death in organisms 
was reported in the 1950‟s by Rita-Levi Montalcini and Viktor Hamburger on neuronal 
cell death in the chick embryo.  These experiments described cell death in response to 
2 
 
limb bud removal (Levi-Montalcini, 1987; Hamburger and Levi-Montalcini, 1949), and 
they later identified the nerve growth factor (NGF) as a molecule that was preventing cell 
death (Levi-Montalcini, 1987).  
 
Morphological Characterization of Cell Death 
The application of electron microscopy to biological specimens beginning in the 
1940‟s enabled more detailed observations of the morphology and organelles present 
within cells (Porter et al., 1945).  The application of electron microscopy to necrotic cell 
death showed swelling of organelles and of the cell (Kerr, 1969; Kerr, 1970).  A separate 
type of cell death (autophagy) was characterized by the formation of lysosomes and 
vacuolar vesicles (Arstila and Trump, 1968).  Later studies on cell death in developing 
tissues revealed the contraction of cells, and the condensation of chromatin which was in 
contrast to the morphology of necrotic cell death (Kerr et al., 1972).  This developmental 
cell death was initially referred to as shrinkage necrosis (Kerr, 1971), and was later 
renamed apoptosis (Kerr et al., 1972).   
 
Genetic Evidence of Apoptosis 
A genetic program underlying cell death was suggested by experiments showing 
that blocking protein and RNA synthesis inhibited cell death in insects and the tadpole 
tail (Lockshin, 1969; Tata, 1966).  The identification of specific cell death genes was 
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initiated by the use of C. elegans as a model system for cell death.  In these organisms 
131 of 1090 cells undergo cell death (Sulston and Horvitz, 1977; Sulston et al., 1983).  A 
close analysis of the lineage and fates of individual cells showed that the same cells were 
reproducibly eliminated (Sulston, 1976), indicating that the deaths were not only 
regulated on the organism level, but are also programmed at the level of single cells.  
Apoptosis genes were identified by mutagenizing somatic cells of C. elegans, and 
screening for cell death abnormal (ced) mutants (Ellis and Horvitz, 1986).  Several 
mutants were found to have defects in apoptosis including ced-3 and ced-4, both of which 
are absolutely required for cell death (Ellis and Horvitz, 1986).   
A separate genetic analysis using insects as a model systems uncovered several 
proteins involved in programmed cell death.  In cells from the moth Spodoptera 
frugiperda it was noted that mutations to the the baculovirus p35 gene could result in 
apoptosis after viral infection which could be rescued by a homologous gene termed iap 
present in another insect virus (Crook et al., 1993).  Shortly afterwards, a genetic screen 
identified a cluster of genes required for almost all programmed cell death in Drosophila 
embryogenesis (White et al., 1994).  The characterization of this locus resulted in the 
identification of the apoptosis genes reaper, hid and grim (Chen et al., 1996; Grether et 
al., 1995; White et al., 1994) which facilitate apoptosis.  Later the physiological target of 
the proteins encoded by these apoptosis inducing genes was identified (Drosophila 
Inhibitor of Apoptosis Protein 1) which was shown to have homology to the apoptosis 
repressing baculovirus p35 gene (Goyal et al., 2000).  Subsequent analysis of these 
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molecules suggested a system repressing programmed cell death, and a mechanism to 
relieve the repression (reviewed in (Kornbluth and White, 2005)).   
Insights into the genetics of mammalian programmed cell death resulted from the 
cloning and characterization of the Bcl-2 proto-oncogene.  The Bcl-2 gene was identified 
at the chromosomal breakpoint t(14;18) in human B cell lymphoma (Bakhshi et al., 
1985).  Unlike most other oncogenes identified at the time, Bcl-2 did not induce 
proliferation, but instead prevented cell death (Vaux et al., 1988).  This was not only 
demonstrated in cell culture, but also in mice over-expressing Bcl-2 along with c-myc - 
which developed leukemia (McDonnell and Korsmeyer, 1991; Strasser et al., 1990), and 
in Bcl-2 knockout mice developed excessive cell death of lymphocytes and melanocytes 
(Veis et al., 1993).  Importantly, the over-expression of Bcl-2 in C. elegans had had a 
protective effect on cell death in C. elegans (Vaux et al., 1992).  This not only 
demonstrated a cell death defect in human pathology, but also that cell death components 
in vastly different species is functionally conserved (Vaux et al., 1992).  Since the 
demonstration of an apoptotic genetic program, many apoptosis genes and molecules 
have been characterized.   
 
Molecular Components of Apoptosis Signaling 
Below we give an overview of the molecules involved in mammalian apoptosis.  
Two non-distinct apoptotic pathways have been defined based on whether the triggering 
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mechanism is internal to the cell (intrinsic apoptosis), or whether the apoptotic trigger is 
external to the cell (extrinsic apoptosis) (Ow et al., 2008).  Some intrinsic triggers include 
DNA damage, endoplasmic reticulum (ER) stress, or microtubule stress.  External stimuli 
are often ligands which bind to receptors on the surface of the cells, and initiate signaling 
that culminates in the death of the cell (Fulda and Debatin, 2006).  Example ligands 
include tumor necrosis factor α (TNFα) (Carswell et al., 1975), the TNF α related 
apoptosis inducing ligand (TRAIL) (Wiley et al., 1995), and Fas Ligand (Suda et al., 
1993).  Nonetheless, it is important to consider the overlap between molecules stimulated 
by different triggers, and that these pathways may not actually be distinct. 
Below is a description of some of the molecules and processes which occur in 
response to apoptotic stimuli.  These include the Bcl-2 family, mitochondrial associated 
proteins (including cytochrome c and Smac), and the caspase family of proteases. 
 
Mitochondria Overview 
Mitochondria play a central role in the oxidative phosphorylation cycle and thus 
in the generation of cellular ATP (Slater, 1977).  Electron microscopy studies of 
mitochondria revealed the substructure of mitochondria which includes the outer 
mitochondrial membrane (OMM), the intermembrane space (IM), the inner 
mitochondrial membrane (IMM), and the mitochondrial matrix (Palade, 1953).  The IMM 
is organized in a manner that creates invaginations into the matrix called cristae spaces 
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(Palade, 1953; Frey and Mannella, 2000).  Several membrane bound complexes exist on 
the IMM which transport protons and other ions in or out of the mitochondrial matrix 
(Schultz and Chan, 2001).  The transport of protons creates a membrane potential (∆Ψ) 
across the IMM which is required for the synthesis of ATP.  The presence of a potential 
across the IMM can be observed by the accumulation of lipophilic cations (such as 
TMRE and TMRM), which preferentially accumulate actively respiring mitochondria 
(Ehrenberg et al., 1988). 
Mitochondria are highly dynamic organelles which fission and fuse with other 
mitochondria (Bereiter-Hahn and Voth, 1994).  The fission and fusion of mitochondria 
are regulated by several proteins such as dynamin related protein 1 (Drp1), Fis1, Bax, and 
many other proteins (Hoppins et al., 2007).  Several human disorders are associated with 
mutations in fission and fusion genes  including Charcot-Marie-Tooth-subtype 2A and 
dominant optic atrophy (Alexander et al., 2000; Pedrola et al., 2005).  Notably some of 
these fission/fusion proteins are also involved in apoptosis (Suen et al., 2008).   
 
Mitochondrial Role in Apoptosis 
The mitochondrial localization of Bcl-2 in mammals and ced-4 in C. elegans 
suggested that the mitochondria play significant roles in apoptosis (Hockenbery et al., 
1990).  Since then various proteins associated with the mitochondria have been 
discovered to be involved in apoptosis.  Some of these molecules include the Bcl-2 
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family of molecules, cytochrome c, Smac/DIABLO, and Omi, among many others (Ow 
et al., 2008).  Furthermore, modifications to the mitochondria structure occur during 
apoptosis including mitochondrial fission and fragmentation (ROUILLER, 1957; Zhuang 
et al., 1998), loss of mitochondrial intermembrane space potential (Goldstein et al., 
2000), and changes in the geometry of the mitochondria cristae spaces (Sun et al., 2007).  
Below we discuss some of the mitochondrial associated molecules relevant to this thesis 
and their involvement in apoptosis. 
 
Bcl-2 Family  
The Bcl-2 family of proteins play critical roles in the release of mitochondrial 
proteins during apoptosis (Kluck et al., 1997; Yang et al., 1997).  The expression and 
concentration of specific Bcl-2 molecules have been proposed to determine the sensitivity 
of cells to some apoptotic signals and some chemotherapies (Danial and Korsmeyer, 
2004; Deng et al., 2007).  Bcl-2 itself was identified at the chromosomal breakpoint of 
t(14;18) in human B cell lymphoma (Bakhshi et al., 1985; Cleary and Sklar, 1985).  
Further Bcl-2 related molecules were identified through protein-protein interactions or 
based on sequence homology.  At least 19 Bcl-2 molecules have been identified to play a 
role in apoptosis (Wang and Youle, 2009).  These molecules can be classified based on 
the presence of four Bcl-2 Homology (BH) domains, and their presumptive role in 
apoptosis (Table 1, Figure 1) (Danial and Korsmeyer, 2004).   
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TABLE 1: Bcl-2 molecules 
BH3 Only Anti-Apoptotic Pro-Apoptotic 
Bad 
Bim 
Bid 
Noxa 
Puma 
Bik 
Hrk 
Bmf 
Bcl-2 
Bcl-XL 
Mcl1 
A1 
Bcl-W 
Bcl-Rambo 
Bcl-L10 
Bcl-10 
Bax 
Bak 
Bok 
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Figure 1: Proposed roles of Bcl-2 and mitochondrial proteins during apoptosis.  
Anti-apoptotic (blue) and BH3-only (orange) molecules control the activity of the 
pro-apoptotic (yellow) Bcl-2 molecules.  Oligomerization of pro-apoptotic molecules 
results in the release of mitochondrial proteins such as cytochrome c and Smac.  The 
diagram does not include all known Bcl-2 molecules. 
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Bcl-2 molecules have a variable number of the four distinct BH3 domains.  The 
number of domains roughly correlates with the apoptotic function of the molecule 
(Danial and Korsmeyer, 2004).  Pro-apoptotic molecules (such as Bax and Bak) possess 
BH domains 1-3, and are directly involved in the release of apoptotic mitochondrial 
proteins (Chittenden et al., 1995; Zha et al., 1996a).  The BH3-only molecules enable the 
apoptotic function of Bax and Bak either by direct or indirect stimulation (Boyd et al., 
1995; Lomonosova and Chinnadurai, 2008).  The third category of Bcl-2 molecules 
possesses BH1-4 domains, and inhibit the pro-apoptotic or the BH3-only molecules 
(Muchmore et al., 1996; Danial and Korsmeyer, 2004).  The subcategories of the Bcl-2 
family are discussed in more detail below.  Notably, there is significant controversy on 
the interactions of the Bcl-2 molecules and how they permeabilize the mitochondrial 
outer membrane (Antignani and Youle, 2006; Chipuk et al., 2010). 
 
Bax/Bak 
During apoptosis Bax and Bak undergo conformational changes and oligomerize 
at discrete sites on the mitochondria (Nechushtan et al., 2001).  The oligomerization of 
Bax and Bak is proposed to result in the permeablization of the mitochondria and the 
release of cytochrome c, Smac/DIABLO and other molecules involved in the execution 
of apoptosis.  A double knockout of Bax and Bak blocks the release and inhibits caspase-
3 processing and activity in response to intrinsic stimuli (Wei et al., 2001).  While 
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extrinsic stimuli such as TNFα is still able to induce caspase activation in Bax/Bak 
double knockout cell lines, it is not able to induce cytochrome c release (Wei et al., 
2001).   
Bax is a monomeric protein that is localized in the cytoplasm and loosely 
associated with mitochondria (Hsu et al., 1997).  It is comprised of 9 α-helices which 
form a hydrophobic pocket that is occupied by its C-terminal helix in its inactive state 
(Suzuki et al., 2000).  During apoptosis Bax translocates to the mitochondria, and inserts 
into the outer membrane (Nechushtan et al., 2001; Gross et al., 1998), with liposomal 
assays suggesting that α-helices 5, 6, and 9 insert into the outer mitochondrial membrane 
(Annis et al., 2005).  Bax then proceeds to oligomerize at discrete sites on the 
mitochondria rather than uniformly throughout the mitochondria (Nechushtan et al., 
2001; Lovell et al., 2008).  Although large Bax oligomers form on the mitochondria, 
experiments on isolated mitochondria or on liposomes suggest that only a few molecules 
are minimally required for permeabilization (Saito et al., 2000; Martinez-Caballero et al., 
2009).  Furthermore, live cell imaging of Bax fused to the green fluorescent protein 
(GFP) indicates that the majority of Bax accumulation at the mitochondria occurs after 
the permeabilization of the mitochondrial outer membrane (Dussmann et al., 2010). 
Unlike Bax, Bak is constitutively associated with the mitochondrial membrane 
and the endoplasmic reticulum (Zong et al., 2003; Wei et al., 2000).  Prior to apoptosis 
Bak can associate with anti-apoptotic proteins such as Mcl-1 and Bcl-xL (Willis et al., 
2005), and also with VDAC (Cheng et al., 2003).  However, co-immunoprecipitation 
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experiments suggest that Bax and Bak are not all be constitutively associated with anti-
apoptotic Bcl-2 proteins, and may exist as monomers (Hsu and Youle, 1997; Cheng et al., 
2001).  The precise mechanism of how Bax/Bak is activated and regulated by other Bcl-2 
members is unclear, though several models have been proposed to explain their 
regulation (Chipuk and Green, 2008); these are discussed in more detail in a later section.  
Nonetheless, during apoptosis Bak redistributes on the mitochondria and electron 
microscopy images indicate that Bak is found at discrete sites after apoptotic stimuli 
(Nechushtan et al., 2001).  Bax and Bak double knockout lines also display altered 
mitochondrial morphology and mitochondrial fusion (Karbowski et al., 2006) which may 
suggest a link between mitochondrial morphology and apoptosis, or non-apoptotic 
functions of Bax and Bak. 
Various mechanisms have been proposed for how Bax and Bak mediate the 
release of cytochrome c.  These include the formation of a proteolipid pore or channel 
(Basanez et al., 2001; Martinez-Caballero et al., 2009), and the modification of an 
existing channel (Kroemer et al., 2007).  Evidence supporting the role of a modified pore 
is based on the ability of Bax to accelerate the opening of a voltage dependant ion 
channel (VDAC) in liposomes (Shimizu et al., 1999).  VDAC along with the adenine-
nucleotide translocase (ANT) was proposed to form the permeability transition pore 
(PTP) which induces the swelling of the matrix, the rupturing of the mitochondria, and 
the release of cytochrome c.  However, knockouts of VDAC or ANT do not recapitulate 
the phenotype of the Bax/Bak double knockout (Baines et al., 2007; Kokoszka et al., 
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2004).  Nonetheless it is possible that another modified channel is necessary for 
cytochrome c release but has not been identified.   
Some evidence support the existence of Bax/Bak protein pores.  First Bcl-2 
proteins are structurally similar to bacteria pore toxins suggesting Bax and Bak may 
permeabilize the OM in a similar way (Muchmore et al., 1996).  Furthermore, Bax can 
permeabilize synthetic liposomes which lack the additional proteins present in the 
mitochondrial membrane (Saito et al., 2000).  However, while the existence of a channel 
or a pore has been proposed with Bax or Bak as the major component, key structural and 
biochemical evidence of a pore is lacking (Antignani and Youle, 2006; Chipuk and 
Green, 2008). 
 
Bcl-2 Inhibitors 
Several Bcl-2 molecules inhibit the association of Bax and Bak into oligomers.  
These include Bcl-2, Bcl-xL, Bcl-W, MCL-1 and A1.  Individual Bcl-2 anti-apoptotic 
molecules are proposed to have specific interactions with Bax and Bak (Willis et al., 
2007) or with the BH3 only proteins (Chen et al., 2005; Letai et al., 2002; Kim et al., 
2006).  However there is some disagreement on the interactions between anti-apoptotic 
and pro-apoptotic proteins (Chipuk and Green, 2008).  For example one 
immunoprecipitation study found that Bcl-xL is associated with Bak prior to apoptosis 
(Willis et al., 2005), whereas another study did not detect an interaction (Cheng et al., 
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2001).  Several possibilities explaining this difference could include an experimental 
difference in cell types, expression levels or in purification processes.  More generally, 
the precise mechanism of inhibition, and the nature of these interactions remain unclear 
and are discussed in detail below (see Models of Bax/Bak Activation).  Several drugs 
have been designed to inhibit Bcl-2 anti-apoptotic proteins to enable the progression of 
apoptosis in tumors or tumor cells (Oltersdorf et al., 2005; Nguyen et al., 2007). 
 
Bcl-2 Sensitizers and BH3-Only Proteins 
The activation of Bax and Bak depends in part on the state of a subset of the Bcl-2 
family called the BH3-only proteins (Wang et al., 1996).  These include Bad, Bim, Bid 
and Noxa/Puma among other proteins (Giam et al., 2008).  The activity of the BH3-only 
proteins can be modified post-translationally.  These can include the inactivation of Bad 
and the activation Bim by phosphorylation events (Harada et al., 1999; Lei and Davis, 
2003).  Additionally, the pro-apoptotic function of Bid results from the cleavage of the 
amino terminal resulting in truncated Bid (tBid) (Zha et al., 1996b; Li et al., 1998; 
Hubner et al., 2008).   
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Models of Bax and Bak Activation 
Two often cited models have been proposed to explain the mechanism by which 
the Bcl-2 pro- and anti-apoptotic molecules proteins activate the Bax and Bak effector 
molecules.  One model proposes that Bax and Bak can be directly activated by a subset of 
BH3 only molecules which interact with and structurally modify the effector proteins, 
and that the remaining BH3 molecules can alter the apoptotic sensitivity of mitochondria 
by inhibiting anti-apoptosis Bcl-2 proteins, but cannot themselves directly activate Bax or 
Bak (Kim et al., 2006).  For example, it is thought that tBid (an activated and cleaved 
form of Bid) enables the association of Bax with mitochondria membrane based on in 
vitro liposomal experiments in the absence of other proteins (Lovell et al., 2008).  More 
generally, of the BH3 peptides from BH3 only proteins, only Bid, Bim and Puma 
peptides were able to induce Bax mediated liposomal or mitochondrial permeabilization 
without the addition of other proteins (Letai et al., 2002).  One of the objections to this 
model is the poorly detected interaction between Bax/Bak and the direct activator 
proteins (Willis et al., 2007) – which could indicate a transient interaction, but may also 
indicate that a direct activation of Bax and Bak is not a physiologically relevant signal.   
Alternatively, it is possible that the BH3 only proteins interact with the Bcl-2 
inhibitors, there by disengaging Bax or Bak from the anti-apoptotic inhibitor .  In these 
models, Bcl-2 inhibitors would constantly keep Bax or Bak from being activated until 
disengaged by the BH3 only molecules (Adams and Cory, 2007).  In support of this 
model is that while BH3 only peptides can engage Bax or Bak (Letai et al., 2002), there is 
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little or no interaction between these BH3 proteins and Bax/Bak in cells (Willis et al., 
2007).  Moreover, there is detectable interaction between over expressed anti-apoptotic 
proteins with Bak (Willis et al., 2005).  One of the objections to this model is that several 
immunoprecipitation experiments indicate that Bax and Bak exist as monomers in vivo 
(Hsu and Youle, 1997; Cheng et al., 2001).  These unattached and yet inactive Bax/Bak 
molecules are in apparent contradiction to this model – though one possibility is that 
there are other forms of Bax/Bak sequestering and inhibition that is not fully understood.  
Finally, another possibility is that both of these models are insufficient to explain the Bcl-
2 family interactions, and a newer model is needed. 
 
Cytochrome c 
Cytochrome c was initially discovered for its role in the electron transport chain 
and in the production of ATP (Slater, 1977).  It is synthesized in the cytosol, and is 
imported into the mitochondria where it acquires a heme group.  The heme group consists 
of an iron molecule which can covert between Fe2+ and Fe3+, thus enabling cytochrome 
c to serve as an electron donor and acceptor.  In the context of the electron transport 
chain, cytochrome c transports electrons between Complex III and Complex IV (Schultz 
and Chan, 2001).  Cytochrome c is predominantly localized to the intermembrane space 
of mitochondria and is thought that 85% of mitochondrial cytochrome c resides in the 
cristae spaces of the mitochondria (Bernardi and Azzone, 1981) where it associates with 
cardiolipin (Ott et al., 2007). 
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Early cell-free experiments indicated the depletion of mitochondria from Xenopus 
extracts reduced caspase activity suggesting that a mitochondrial protein is required for 
the activation of caspase-3 (Newmeyer et al., 1994).  Using biochemical and 
centrifugation techniques caspase activation was shown to require cytochrome c, ATP, 
and another factor called the apoptosis protease activating factor-1 (Apaf-1) (Liu et al., 
1996).  Cell lines derived from knockout cytochrome c mice show reduced caspase-3 
activation, however are able to undergo apoptosis in response to some stimuli (Li et al., 
2000).  Knocking in a mutagenized cytochrome c (K72A) that functions in the electron 
transport chain, but does not bind to Apaf-1 results in mice in which the majority died 
prenatally, but with a few that were able to survive for several weeks (Hao et al., 2005). 
Furthermore, while K72A MEFs are resistant to apoptosis induced by UV irradiation, 
K27A thymocytes display a similar apoptosis response as the wild-type cytochrome c 
thymocytes (Hao et al., 2005).  Thus, the survival of some of the K27A mice, along with 
the similar apoptosis response of K72A thymocytes suggests that there may be 
cytochrome c independent mechanisms required for apoptosis. 
Once in the cytosol, cytochrome c can interact with individual molecules of Apaf-
1 (Zou et al., 1997).  These molecules then oligomerize into a complex called the 
apoptosome which is able to induce caspase activity (Li et al., 1997; Zou et al., 1999).  
Furthermore, once cytochrome c relocalizes from the mitochondria to the cytosol, it can 
also interact with the inositol triphosphate receptor (IP3R) which is embedded in the 
endoplasmic reticulum (ER) and controls calcium release (Boehning et al., 2003).  The 
cytochrome c- IP3R interaction is proposed to enable the release of calcium from the ER, 
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which in turn can induce the release of cytochrome c from other mitochondria, thus 
amplifying the initial release cytochrome c (Boehning et al., 2003; Boehning et al., 2005). 
Cytochrome c-GFP fusions have been found to localize to mitochondria prior to 
apoptosis, however this takes considerable time (>48 hours) to properly localize to 
mitochondria (personal communication D. Boehning).  The release of cytochrome c GFP 
from mitochondria is complete within minutes, and is proposed to occur in a spatially 
invariant manner through the cell (Goldstein et al., 2000; Munoz-Pinedo et al., 2006).  
Coincident with the release of cytochrome c, mitochondrial intermembrane potential 
(∆Ψ) is also lost, though inhibitors of caspase activation can delay ∆Ψ loss (Munoz-
Pinedo et al., 2006).  Nonetheless, the acquisition frequency of the images in these 
studies is similar to the phenomenon that is being imaged, thus potentially masking finer 
dynamic behavior. 
  
Smac/DIABLO 
During apoptosis, Smac/DIABLO (second mitochondria-derived activator of 
caspases / direct IAP-binding protein with low pI) is also released from the mitochondria 
(Du et al., 2000; Verhagen et al., 2000).  Smac is synthesized in the cytosol and when 
imported into the mitochondria, the 55 N-terminal amino acids are cleaved resulting in 
the 4 amino acids at the N-terminal AVPI (Burri et al., 2005).  The processing of Smac 
and the post-translocation AVPI amino terminal plays a role in promotion of caspase 
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activity (Wu et al., 2000).  The processed form of Smac resides in the intermembrane 
space of mitochondria, with crystallography and biochemical data suggesting that it exists 
as a homodimer (Chai 2000).  Once released into the cytosol, Smac can interact with 
Inhibitor of Apoptosis (IAP) proteins which themselves can directly inhibit or antagonize 
caspase activity (Verhagen et al., 2000; Du et al., 2000).  Smac is proposed to inhibit IAP 
activity by substrate competition, direct IAP binding and inhibition or by inducing IAP 
degradation (Lacasse et al., 2008).  The precise mode of inhibition is somewhat unclear 
and depends on the specific IAP; this is discussed in more detail in a later section.   
Splice variants of Smac include Smac-beta, and Smac3.  Smac-beta does not 
localize to the mitochondria, and does not bind to IAPs, however, its overexpression can 
predispose cells to certain apoptosis stimuli (Roberts et al., 2001).  By comparison, 
Smac3 does localize to mitochondria, is released during apoptosis, and can trigger 
degradation of XIAP (Fu et al., 2003).  Smac knockout mice are viable, and still undergo 
apoptosis in response to a variety of stimuli (Okada et al., 2002).  One possibility 
explaining the viability of Smac knockout mice is the redundancy of Smac in apoptosis, 
or alternatively, a splice variant may compensate for the Smac knockout. 
Smac release is presumed to occur at the same time as cytochrome c release 
(Munoz-Pinedo et al., 2006), and it has been suggested that they are released by the same 
mechanism.  However this order may depend on the apoptosis inducing drug and the 
genetic background of the cell.  For example in mouse embryonic fibroblasts (MEFs) 
from Bid, Bad or Bak single knockout mice, in response to TRAIL treatment, Smac 
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release is inhibited while cytochrome c release occurs (Kandasamy et al., 2003).  This 
suggests that different mitochondrial modifications may be needed for Smac or 
cytochrome c release.  Even more interesting is that Smac release is inhibited in 
cytochrome c KO mice (Hansen et al., 2006).  This may indicate a feedback loop in 
which cytosolic cytochrome c is required for Smac release in single cells. 
 
Apaf-1 
Apaf-1 forms a critical part of the apoptosome which activates the caspase-9, and 
in turn caspase-3 (Li et al., 1997; Zou et al., 1997).  While the majority of Apaf-1 
knockout mice are embryonic lethal, (depending on the genetic background of the mice), 
a small percentage can survive to adulthood (Yoshida et al., 1998; Honarpour et al., 
2000).  MEFs isolated from Apaf-1 knockout mice undergo apoptosis, and are more 
resistant to some apoptotic triggers than the cytochrome c K72A knockin mice suggesting 
that there may be cytochrome c independent but Apaf-1 dependant mechanisms to induce 
apoptosis (Hao et al., 2005). 
Apaf-1 consists of a caspase recruitment domain (CARD) and two WD40 
domains (Hu et al., 1998; Li et al., 1997).  Prior to cytochrome c release from the 
mitochondria, Apaf-1 exists as a cytosolic monomer with its CARD domain bound to its 
WD40 domain (Acehan et al., 2002; Li et al., 1997; Zou et al., 1999).  When released into 
the cytoplasm, cytochrome c binds to the Apaf-1 WD40 domain exposing the CARD 
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domain.  The presence of ATP enables the oligomerization of Apaf-1 into a wheel like 
structure consisting of approximately 7 Apaf-1 proteins (Acehan et al., 2002; Li et al., 
1997), with the Apaf-1 CARD domains located in the center.  The CARD domains bind 
to caspase-9 thus forming the macromolecular complex called the apoptosome (Zou et 
al., 1999).  It is proposed that the proximity of caspase-9 at the center of the apoptosome 
enables the activation of caspase-9 (Li et al., 1997; Rodriguez and Lazebnik, 1999; 
Stennicke et al., 1999) 
 
Other Mitochondrial Modifications during Apoptosis 
During apoptosis, the structure of the mitochondria undergoes several changes.  
Mitochondria cristae junctions become wider, and at a later time the cristae structure 
changes from being long and tubular, to spherical and round (Sun et al., 2007).  Opa1 – a 
protein that is localized in a macromolecular complex at the cristae junction – is cleaved 
during apoptosis enabling the widening of the cristae (Pellegrini and Scorrano, 2007).  
This is proposed to allow the passage of cytochrome c out of the cristae space (Scorrano 
et al., 2002).  However, the temporal ordering of Opa1 cleavage and cytochrome c 
relocalization within the mitochondria has yet to be directly measured.   
Mitochondria also become fragmented during apoptosis, and in some instances 
swell.  This was initially thought to be a mechanism of release of cytochrome c, but direct 
imaging shows that cytochrome c release occurs before significant swelling (Goldstein et 
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al., 2005).  Mitochondria also lose their membrane potential during apoptosis at a similar 
time as cytochrome c release (Munoz-Pinedo et al., 2006).  However, the addition of 
caspase inhibitors delays loss of membrane potential, while still enabling cytochrome c 
release (Goldstein et al., 2000). 
 
Caspases 
Caspases are a family of proteases that are involved in apoptosis, inflammation, 
differentiation, and neuronal pruning, among other functions (Kumar, 2007).  In 
mammalian cells, at least fourteen caspases have been identified and are referred to as 
caspase-1 through caspase-14 according to defined nomenclature (Alnemri et al., 1996).  
The caspases are characterized by a cysteine nucleophile in their active site, and the 
requirement for cleavage of substrates after aspartic acids (aspase) (Thornberry et al., 
1992).  Caspases are translated as inactive precursors called zymogens or procaspases 
which zymogens contain an inhibitory N-terminal prodomain of variable size, and a large 
and small subunit (17-20 kDa and 10-12 kDa respectively) (Yan and Shi, 2005).  The 
activation of caspases represents a critical step in the progression of apoptosis resulting in 
the cleavage of transcription factors, translation factors, cellular structures, among other 
vital cellular components (Dix et al., 2008; Timmer and Salvesen, 2007). 
Caspase-1 was the first identified mammalian caspase as the protease responsible 
for the cleavage and activation of the precursor of IL-1β, and was accordingly named IL-
23 
 
1β Converting Enzyme (Cerretti et al., 1992).  Shortly afterwards, the molecular 
characterization of the protein encoded by the C. elegans ced-3 gene resulted in 
identification of an enzyme with significant homology to the active region of caspase-1 
(Yuan et al., 1993).  Since these initial discoveries, families of caspases have been 
discovered in various organisms identified and were found to play a role in apoptosis 
(and other processes) (Vaux and Korsmeyer, 1999). 
Caspases-2,-3,-6,-7,-8,-9 and -10 play roles in response to various apoptotic 
stimuli.  These are classified as initiator caspases  or as executioner caspases based on the 
length of their prodomains, and on their presumed  function in apoptosis (Table 1) (Yan 
and Shi, 2005).  Initiator caspases are activated early in apoptosis and have prodomains 
that are longer than 90 amino acids.  These pro-domains enable the association with other 
molecules required for caspase activation (Yan and Shi, 2005).  In contrast executioner 
caspases have significantly shorter prodomains (20-30 amino acids), are active late in 
apoptosis, and when activated, cleave a large number of cellular substrates (Dix et al., 
2008; Timmer and Salvesen, 2007).  The early/late involvement is largely based on 
genetic evidence (Kumar, 2007) and immunodepletion of in vitro cultures (Slee et al., 
1999).  Thus, these experiments do not preclude the existence of overlapping activities, or 
of a synergistic relationship between initiator and executioner caspases. 
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Table 2: Classification of Apoptotic Caspases 
Initiator Executioner 
Caspase-9 
Caspase-8 
Caspase-10 
Caspase-2 
Caspase-3 
Caspase-6 
Caspase-7 
 
 
Caspase-9 
Once released from the mitochondria, cytochrome c and Apaf-1 associates with 
caspase-9 to form the apoptosome which in turn processes and activates caspase-3 (Li et 
al., 1997).  After translation, caspase-9 is localized in the cytosol and exists as a 
monomer (Stennicke et al., 1999; Renatus et al., 2001).  It consists of an N-terminal pro-
domain with a caspase recruitment domain (CARD) which is responsible for the 
association of caspase-9 with Apaf-1 (Li et al., 1997).  Caspase-9 knockout mice reveal 
excessive brain tissue resulting from decreased apoptosis, and are embryonic or perinatal 
lethal depending on the genetic background (Hakem et al., 1998; Kuida et al., 1998). 
While caspase-9 can be cleaved, the activation of caspase-9 does not require the 
removal of its N-terminal prodomain (Stennicke et al., 1999).  Two hypothesis exist for 
the activation of caspse-9: the induced proximity model and the allosteric model 
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(Boatright and Salvesen, 2003; Shi, 2004).  The allosteric model proposes that caspase-9 
monomers are activated directly (Rodriguez and Lazebnik, 1999), while the induced 
proximity model proposed that the association of caspase-9 monomers in the apoptosome 
brings caspase-9 close together which enables the multimerization of caspase-9 and thus 
its activation (Boatright et al., 2003).   
 
Caspase-3 and Caspase-7 
In mammalian cells, caspase-3 is presumed to be the major executioner caspase 
that cleaves the majority of cellular substrates.  Caspase-3 can be processed and activated 
by initiator caspases such as caspase-8, and -9, or by executioner caspases such as 
caspase-7 and caspase-3 itself (Pop and Salvesen, 2009).  Several substrates of caspase-3 
include poly(ADP-ribose) polymerase (PARP), actin, and many other vital cellular 
proteins (Dix et al., 2008; Timmer and Salvesen, 2007).  Caspase-7 is highly similar to 
caspase-3 based on sequence homology, and based on the cleavage of preferred 
substrates (Fuentes-Prior and Salvesen, 2004; Thornberry et al., 1997).  Furthermore, 
their inactive and active structures show similar features (Chai et al., 2001; Mittl et al., 
1997; Riedl et al., 2001; Rotonda et al., 1996).   
Shortly after translation, caspase-3 and caspase-7 zymogens form inactive dimers 
in the cytosol (Yan and Shi, 2005).  In this pre-apoptotic form, the activity of executioner 
caspases is inhibited by the presence of the prodomain and by spacers between the large 
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and small subunits (Boatright and Salvesen, 2003).  Executioner caspases are processed 
by the initiator caspases, resulting in the removal of the pro-domain and cleavage of the 
small and large subunits.  Structural studies indicate that the cleavage of the linker 
between the small and large subunit enables a structural rearrangement and formation of 
the catalytic site (Yan and Shi, 2005).  The result is an active executioner caspase is a 
tetramer consisting of two large and two small subunits (Chai et al., 2001; Mittl et al., 
1997; Riedl et al., 2001; Rotonda et al., 1996).   
Caspase-3 knockout mice were initially thought to be embryonic lethal, with 
significant cell survival in the central nervous system (Kuida et al., 1996).  However, in 
different genetic backgrounds, caspase-3 knockout mice survive to birth, with 
cardiovascular defects (Lakhani et al., 2006).  Similar results are seen of caspase-7 
(Lakhani et al., 2006).  These single knockout experiments suggest that caspase-3 and 
caspase-7 are not absolutely necessary for apoptosis in all tissues, and that they may have 
overlapping functionality.  While caspase-3 and -7 double knockout mice can survive to 
birth, they die shortly afterwards, and display significant heart development problems 
(Lakhani et al., 2006).  Furthermore, the double knockout mice show delayed 
mitochondrial permeabilization suggesting that there may be a caspase feedback loop to 
amplify cytochrome c release (Lakhani et al., 2006). 
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Caspase-8 and Caspase-10 
Caspase-8 and caspase-10 are important components of apoptosis induced by 
extracellular ligands such as TRAIL, sFasL or TNFα (Muzio et al., 1996; Boldin et al., 
1996).  Caspase-8 knockout mice are embryonic lethal with defects in cardiac and T-cell 
development (Varfolomeev et al., 1998).  The defects in the KO mice result in a lack of 
apoptosis induced by death receptors, however apoptosis still occurs in response to 
intrinsic stimuli (Varfolomeev et al., 1998).  Caspase-8 consists of an N-terminal 
prodomain with 2 repeats of the death effector domain (DED).  The DED enables 
association with the death domains (DD) in the adaptor proteins FADD and TRADD 
(Boldin et al., 1996; Carrington et al., 2006).  In response to sFasL, caspase-8 associates 
with a macromolecular complex called the death induced signaling complex (DISC) at 
the plasma membrane resulting in caspase-8 activation (Lee et al., 2006).  In contrast, 
when cells are treated with TNFα, caspase-8 does not associate with the DISC at the 
plasma membrane, but instead forms an oligomer with FADD in the cytosol where 
caspase-8 is activated (Micheau and Tschopp, 2003).  The mechanism of caspase-8 
activation remains unclear and is proposed to auto-activate upon close proximity (Lee et 
al., 2006).  Once activated casapase-8 can cleave and activate Bid which enables the 
association of Bax with mitochondria and release of cytochrome c from the mitochondria 
(Li et al., 1998).  Alternatively, caspase-8 can directly process and activate caspase-3 
(Stennicke et al., 1998).   
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Caspase-2 
Caspase-2 is an apical caspase that is response the activation of cell death in 
response to DNA damage, TRAIL and heat shock stimulus (Tinel and Tschopp, 2004; Tu 
et al., 2006).  Like other apical caspases, it contains a long pro-domain, which has a 
CARD protein-protein interaction domain (Baliga et al., 2004).  The activation of 
caspase-2 is thought to occur in a similar manner to caspase-9.  Prior to apoptosis, 
caspase-2 is a monomer, and after an apoptotic stimulus, it binds to the protein RAIDD in 
a multimeric scaffolding platform called the PIDDosome (Tinel and Tschopp, 2004).  
Here multiple caspase-2 molecules are brought into close proximity which is thought to 
activate it.   
 
Cleavage Preferences of Caspases 
Several studies have been performed to identify the optimal substrates that will be 
processed by caspases for the purposes of creating specific reporters of caspase activity.  
The initial studies identifying substrate preference were based on fluorogenic substrates 
with four amino acids that bind to the active sites of caspases (Thornberry et al., 1997).  
Caspase-9 prefers the four amino acid sequence „LEHD‟, and caspase-8 prefers the 
sequence „IETD‟.  Caspase-3 and -7 have similar substrate preferences for the sequence 
„DEVD‟, however they are also able to efficiently cleave both LEHD and IETD 
(Thornberry et al., 1997).  Extending the substrate size beyond four amino acids results in 
greater substrate specificity, however there is still considerable overlap (Stennicke et al., 
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2000).  This redundancy is likely a beneficial feature in the event that a particular caspase 
is mutagenized and inactivated, however it makes the design of a reporter for specific 
caspase activity difficult (McStay et al., 2008). 
 
Inhibitor of Apoptosis Proteins 
In contrast to the molecules involved in the activation of caspases, the activation 
of caspases can be inhibited by a class of proteins called the inhibitor of apoptosis family 
(IAP).  The IAP family consists of eight distinct molecules which contain several BIR 
(baculovirus IAP repeat) domains, and in some instances a CARD domain, and a RING 
domain (Salvesen and Duckett, 2002).  The proposed mechanisms of IAP-caspase 
inhibition is specific to an IAP member, and can occur via direct inhibition of active 
caspases, inhibition of caspase processing, or in promoting the degradation of caspases 
(LaCasse et al., 2008).  These are discussed in detail below. 
In Drosophila, the IAP homolog Drosophila IAP-1 (Diap1) functions as a 
ubiquitin ligase which marks Dronc (caspase-9 homolog) for degradation (Wilson et al., 
2002).  In mammalian cells, the clearest demonstration of IAP-caspase inhibition is the 
interaction between caspases-3, 7, and 9, and XIAP (Deveraux et al., 1998).  XIAP can 
bind to caspase-3, 7 and 9, and is proposed to interfere with the active sites of the 
caspases, or with dimerization (Scott et al., 2005; Shiozaki et al., 2003).  Some evidence 
suggests that cIAP1 and cIAP2 can also inhibit caspase activity, though this may occur 
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through a different mechanism than XIAP.  Specifically, studies in yeast indicate that 
activation of exogenous mammalian caspase-3 can be inhibited by the expression of 
cIAP1 and cIAP2 (Wright et al., 2000).  Initially, it was thought that cIAP1 and cIAP2 
are able to bind and directly inhibit caspase activation (Roy et al., 1997), but later studies 
suggest that while cIAP1/2 can bind to caspases-3/7, the direct inhibition may be an 
experimental artifact (Eckelman et al., 2006).  Alternatively, cIAP1 and 2 may antagonize 
caspase activation by ubiquitination (LaCasse et al., 2008).   
The relief of XIAP inhibition during apoptosis can be in part attributed to the 
release of Smac from mitochondria (Du et al., 2000; Verhagen et al., 2000).  Initially, it 
was thought that Smac antagonizes the XIAP inactivation of caspase-9 by competition 
(Srinivasula et al., 2001).  However Smac is unable to relieve the inhibition between 
BIR3 of XIAP and caspase-9, but is able to relieve the inhibition of caspase-9 by XIAP 
lacking BIR1, suggesting that simple substrate competition may not be the mechanism of 
Smac-XIAP inactivation (Huang et al., 2003).   
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Genetically Encoded Fluorescent Proteins 
We extensively use light and fluorescence microscopy to observe the dynamics of 
various apoptotic events in single cells.  The characterization and cloning of the green 
fluorescent protein (GFP) was a technological advance in the fluorescent tagging of 
proteins (Prasher et al., 1992) (Shimomura, 2009).  GFP is a fluorescent molecule found 
in the jellyfish Aequeora Victoria (Shimomura, 2009).  The application of GFP to 
imaging in organisms first enabled the observation of single cells in C. elegans which had 
specific active promoters (Chalfie et al., 1994), and more recently has been applied to 
simultaneously image many distinct cells in fixed tissues (Livet et al., 2007).   
 
GFP has a specific excitation and emission spectra.  The wild type GFP required 
UV excitation which is not ideal for the long term imaging of cells (Heim et al., 1994).  
Significant work was performed to mutagenize GFP, to improve its spectral properties as 
well as its brightness and photostability (Heim et al., 1995; Heim et al., 1994).  Further 
mutagenesis altered the emission spectra of GFP resulting in the development of the cyan 
fluorescent protein (CFP), the yellow fluorescent protein (YFP) and other fluorescent 
proteins with similar fluorescent properties such as mCerulean, mCitrine (Griesbeck et 
al., 2001; Rizzo et al., 2004).  The discovery of DsRed enabled visualization of proteins 
at longer wavelengths (Matz et al., 1999; Baird et al., 2000).  The mutagenesis of DsRed 
improved its spectral properties, but also enabled the characterization of a monomeric red 
fluorescent protein (mRFP) (Campbell et al., 2002), and later the generation of several 
fluorescent proteins with varied emission wavelengths (mCherry, mOrange, 
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mStrawberry, mPlum) (Shaner et al., 2004).  A diverse set of proteins can be used in 
combination with the appropriate set of spectral filters to separately image different 
molecules.  For example, it is easily possible to image mCerulean, mCitrine, and 
mCherry (Shaner et al., 2005). 
 
Table 3: Genetically Encoded Fluorescent Proteins 
Fluorophore Excitation Emissions 
Cerulean 433 475 
EGFP 488 507 
mCitrine 516 529 
mCherry 587 610 
(Shaner et al., 2005) 
Caspase and Protease Reporters 
Various reporters of caspase reporters exist which involve a change of 
fluorescence or fluorophore localization upon caspase activation (Figure 2).  Existing 
reporters for live caspase activity include a reporter which undergoes a change in Forster 
Resonance Energy Transfer (FRET) after caspase activation (Nguyen and Daugherty, 
2005; Xu et al., 1998), and a separate reporter that transitions from being in both the 
cytoplasm and the nucleus to being solely in the nucleus after caspase activation 
(pCaspase-3 Sensor, Clontech). 
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Figure 2: Image of existing caspase reporters.  (A) Design of the FRET caspase 
reporter.  (B) Prior to caspase activation, CFP and YFP molecules are proximal 
resulting in an energy transfer between CFP and YFP.  After caspase activation, 
CFP and YFP are separated resulting in significantly less energy transfer and less 
YFP emission.  (C) Design of the pCaspase-3 sensor.  This consists of a fluorophore 
and a nuclear localization signal (NLS) which are separated from a nuclear export 
signal (NES) by a DEVD amino acid linker.  (B) The pCaspase-3 sensor initially 
exists in both the cytoplasm and the nucleus.  After caspase activation, the nuclear 
export signal is removed and the fluorophore relocalizes to the nucleus. 
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The FRET reporter consists of two fluorophores which are held together by a 
linker region which contains the amino acids DEVD (Figure 2A,B).  The close proximity 
of the two fluorophores enables a non-photon mediated energy transfer (Andrews, 1989) 
from an excited donor fluorophore to the acceptor fluorophore, and thus emission from 
the acceptor fluorophore at its characteristic emission signature.  Upon caspase activity 
the DEVD linker is cleaved resulting in the separation of the fluorophores, loss of the 
energy transfer, and therefore the loss of emission from the acceptor fluorophore.  
Although monitoring the activation of caspase-3/7 can be achieved with FRET reporters, 
these reporters require the use of two fluorescent proteins, and therefore use a significant 
portion of the visible spectrum (Nguyen and Daugherty, 2005; Xu et al., 1998).  As 
result, they limit the ability to use additional independent fluorophores to probe signaling 
molecules or other cytosolic activities.  Such probes might include reporters for the cell 
cycle, phosphorylation, and various tagged proteins. 
A separate reporter sold by Clontech called the pCaspase-3 sensor is an 
alternative genetically encoded caspase reporter (figure 2C,D).  This reporter consists of a 
nuclear export signal (NES), a DEVD linker, a fluorophore, and a nuclear localization 
signal (NLS).  After caspase activation, the NES is removed and the reporter relocalizes 
from the nucleus and cytosol to the nucleus alone after caspase activation.  However one 
of the concerns is the various strengths of the NES or NLS in different cells can lead to 
improper nuclear localization prior to caspase activation. 
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Variability in Commitment to Apoptosis 
Cells destined to undergo apoptosis in response to internal stresses and some 
external stresses release cytochrome c and Smac from mitochondria (Ow et al., 2008), 
and within minutes activate caspases-3 and -9  (Rehm et al., 2003).  In contrast to the 
tight timing between these events, the duration of events preceding cytochrome c release 
and caspase activation can vary from 1 hour to over 20 hours within a clonal population 
of cells (Goldstein et al., 2000).  This variation is striking considering that the 
biochemical events within this delayed and variable stage determine whether the cell will 
die.   
Population variability has also been documented for other phenotypes including 
phage lambda infection (Arkin et al., 1998), bacterial chemotaxis (Spudich and Koshland, 
Jr., 1976), cell differentiation (Abkowitz et al., 1996; Enver et al., 1998), and HIV-1 Tat 
transactivation (Weinberger et al., 2005). Understanding the sources and dynamics of 
apoptotic variability can lend insight into the precision with which cells are able to 
process extracellular signals.  A number of different factors could contribute to 
population variability of apoptosis including differences in the composition of single 
cells, the local environment of single cells, or stochasticity in biochemical reactions 
triggered by apoptotic stimuli.   
One source of in vitro variability in response to an apoptotic drug could be 
inhomogeneities in extracellular concentrations of secreted pro- and anti-apoptotic 
factors.  Apoptotic factors play a role in apoptosis signal transduction in cultured cells 
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(Janes et al., 2006). However, it is unclear how much the secreted factor contributes to 
the apoptosis variability, or to the shift of apoptosis time of the entire culture.  It also 
possible that these factors act mainly on the secreted cell itself (Loewer and Lahav, 
2006).   
A second source of variability could result from stochasticity of the biochemical 
reactions in response to apoptotic stimuli.  A stochastic transduction of an apoptotic 
signal could be the consequence of just a few molecules being involved in a particular 
stage of apoptosis (Rao et al., 2002).  During apoptosis, factors may re-localize to sub-
cellular regions of the cell including the plasma membrane (Siegel et al., 2004), and the 
endoplasmic reticulum (Boehning et al., 2003).   Along with the synthesis and 
degradation of molecules (Barkett and Gilmore, 1999; Wertz and Dixit, 2008), this may 
create situations where the activation of certain apoptotic factors or complexes may be 
limiting, resulting in stochastic onset of apoptosis, and therefore variability in the 
population (Raychaudhuri et al., 2008). Thus, even when the same initial conditions are 
reproduced, the reaction does not necessarily produce the same result (McAdams and 
Arkin, 1998).   
A third source of population variability is a heterogeneity of cellular factors amongst 
the population (Kaern et al., 2005).  In some instances, variation of protein expression has 
been correlated to the cell cycle (Sigal et al., 2006a).  However, in other instances 
variation in protein expression is uncoupled to the cell cycle, and is a function of the time 
since cells last shared a common ancestor (Sigal et al., 2006b).  The commitment of a 
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single cell to apoptosis likely depends on the concentrations and post-translational 
modifications to the many molecules involved in apoptosis.  
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Chapter Two: Design of Caspase Reporter 
 
Introduction 
We first sought to design a probe for caspase-3/7 activity that was genetically 
encoded facilitate the generation of stable cell lines and for reporting the caspase activity 
in organisms.  Existing reporters for live caspase activity include a reporter which 
undergoes a change in Forster Resonance Energy Transfer (FRET) after caspase 
activation (Nguyen and Daugherty, 2005; Xu et al., 1998), and another reporter that 
transitions from being in both the cytoplasm and the nucleus to being solely in the 
nucleus after caspase activation (pCaspase-3 Sensor, Clontech).   
The FRET reporter consists of a donor fluorophore and an acceptor fluorophore 
which are separated by a DEVD amino acid sequence.  The DEVD sequence is 
preferably cleaved by caspase3/7, though is cleaved by other proteases (Thornberry et al., 
1997).  Prior to caspase activation, excitation of the donor fluorophore results in emission 
from the acceptor fluorophore owing to the close physical proximity of the fluorophores.  
After caspase activation and cleavage of the DEVD sequence, the fluorophores are 
separated resulting in a change of the emission spectra when the donor fluorophore is 
excited.  FRET reporters have been used to monitor caspase activation in cell culture 
(Nguyen et al., 2007) and in organisms (Takemoto et al., 2007).  However, the FRET 
reporter requires two fluorophores which limits the use of orthogonal fluorophores for 
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simultaneously monitoring other processes.  The pCaspase-3 sensor consists of a nuclear 
export signal (NES) at its N terminal, followed by the DEVD sequence, a fluorescent 
protein, and a nuclear localization signal (NLS).  Upon caspase activation, the NES is 
removed and the fluorescent protein is exclusively localized to the nucleus.  One of the 
drawbacks of this reporter is that it depends on strengths of the NES and the NLS in a 
particular cell line.  This is known to have considerable variation, and in our hands results 
in different localization of the reporter prior to caspase activation (data not shown). 
 In this chapter, we describe the generation and characterization of two 
single fluorophore caspase reporters (termed the pmDEVD and erDEVD reporters).  
These reporters are based on the principle of re-localization.  We compared the kinetics 
of these reporters to exiting reporters, and determined the effect on downstream steps of 
apoptosis. 
 
Results 
Reporter Design 
In creating single fluorophore reporters of caspase activity we sought to create 
reporters that changed cellular localization upon caspase activity.  Two reporters were 
constructed: the first reporter was designed to re-localize from the plasma membrane to 
the cytoplasm (pmDEVD) (Figure 3), whereas the second reporter relocalizes from the 
cytoplasmic surface of the endoplasmic reticulum to the nucleus (erDEVD) (Figure 4).  
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The pmDEVD reporter consists of an N-terminal plasma membrane (pm) targeting 
palmitoylation domain from Growth Associated Protein 43 (GAP-43) (Skene and Virag, 
1989) and a fluorescent protein, which are separated by a linker region containing the 
DEVD caspase-3/7 cleavage site (Figure 3A).  The linker region contains the amino acid 
sequence DEVD that has been used to detect caspase-3/7 activity (Thornberry et al., 
1997). Though other caspases will cleave „DEVD‟ - albeit with a lower efficiency 
(Thornberry et al., 1997) - for the sake of consistency of terminology with previous 
publications, we refer to the designed DEVDase reporters as a caspase-3/7 reporters.  The 
pmDEVD reporter was designed so that the fluorophores and the linker region are easily 
interchangeable (see plasmid design in Chapter Six). 
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Figure 3: Design of the plasma membrane DEVD reporter (pmDEVD).  (A) The 
reporter consists of a membrane targeted palmitoylation domain (amino acids 1-21 
from GAP-43), a linker containing the DEVD amino acid sequence, and a 
fluorescent protein (in this case GFP).  (B)  Prior to caspase activation the 
fluorophore (green) is localized to the plasma membrane, and after caspase 
activation it becomes cytosolic. 
 
The erDEVD reporter contains the first endoplasmic reticulum (er) 
transmembrane domain of Sec63 as its N-terminus (Meyer et al., 2000) followed by the 
DEVD linker region, a fluorescent protein, and finally a triple repeat of the SV40 nuclear 
localization signal (NLS) at the C-terminus (Kalderon et al., 1984; Lanford et al., 1986) 
(Figure 4).  The Sec63 domain consists of amino acids 1-63 of Sec63, and this contains a 
protein translocation consensus sequence (Meyer et al., 2000), and a few amino acids 
following the transmembrane domain.  Similar to the pmDEVD reporter, the fluorophore 
in the erDEVD reporter is interchangeable.   
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Figure 4: Design of the endoplasmic reticulum DEVD reporter (erDEVD).  (A) The 
reporter consists of the endoplasmic reticulum translocation domain from Sec63, a 
DEVD amino acid sequence, a fluorescent protein (in this case GFP), and a triple 
repeat of the nuclear localization tag from SV40.  (B)  Prior to caspase activation the 
fluorophore (green) is localized to the endoplasmic reticulum, and after caspase 
activation it becomes localized to the nucleus. 
 
Each reporter is named by its initial localization (er or pm) as well as its 
fluorophore. For example, when the mCherry fluorescent protein is linked via the caspase 
sensitive sequence DEVD to the plasma membrane, the resulting probe is referred to as 
pmDEVD-mCherry. Upon caspase activation the reporters should shift their location 
owing to cleavage of the DEVD caspase sensitive linker.  As a control for whether the 
caspase-sensitive linker region was responsible for any changes in localization, we 
created reporters (pmControl or erControl) that only differed from the pmDEVD or 
erDEVD reporters by the absence of the DEVD cleavage site in the linker region.   
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To test the pmDEVD reporter, we co-expressed the pmDEVD-mCherry and 
pmControl-Cerulean reporters in HeLa cells (Figure 5).  Prior to any treatment, Golgi 
localization of the pmDEVD reporter is observed, which is consistent with earlier 
observations of the palmitoylation localization tag (Figure 5A) (McLaughlin and Denny, 
1999).  After treatment with STS (2 µM), the mCherry fluorescence is relocalized from 
the plasma membrane to the cytosol (Figure 5A).  This was quantified by monitoring the 
fluorescence in a region within the cytoplasm over time (Figure 5B).  In contrast, 
pmControl-Cerulean remained at the plasma membrane (images in Figure 5A and 
quantification in Figure 5B) indicating that the DEVD cleavage site is responsible for the 
change in localization and not the palmitoylation domain.  The lack of change in the 
pmControl-Cerulean signal also indicates that the contraction of apoptotic cells is not 
responsible for the increase in the pmDEVD-mCherry signal.  Thus, the cytosolic 
fluorescence of mCherry could be used to quantify the DEVDase activation. 
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Figure 5: Time lapse images and quantification of the pmDEVD reporter.  (A) 
pmDEVD-mCherry and pmControl-mCerulean reporter expressed in the same 
HeLa cell and treated with 2μM of STS.  The pmDEVD reporter relocalizes to the 
cytosol (top panel) and the pmControl reporter remains membrane associated 
(lower panel).  (B) Quantification of cytosolic fluorescence for the cells in A shows 
and increase in the pmDEVD reporter (red diamonds), but no significant change in 
the pmControl reporter (blue triangles).  Time points with squares correspond to 
the images in A. 
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Similar results were observed when apoptosis was triggered by the addition of 
TNFα (50ng/mL) and cycloheximide (5µg/mL) (data not shown).  Notably with TNFα 
and CHX treatment, the contraction of the cell occurs approximately 30 minutes after 
detectable caspase activity (data not shown).  Though these results were observed with 
confocal microscopy, a similar increase in fluorescence could be observed with wide-
field microscopy (Figure 6).  With wide-field microscopy, prior to any treatment, there is 
an apparent cytosolic fluorescence which is likely out of focus plasma membrane 
associated fluorescence.  When treated with STS (2 μM), there was an increase in the 
cellular fluorescence of the cell as the probe was released from the plasma membrane.  
This net increase in fluorescence suggests that the reporter may be at a high enough 
density at the plasma membrane to partially self-quench.  Alternatively, this may indicate 
out of focus fluorescence entering the focal plane. 
To test the utility of the erDEVD reporter, we transfected HeLa cells with the 
erDEVD-mCherry reporter and the erControl-mCerulean reporter, and treated cells with 
TNFα (50ng/mL) and CHX (5µg/mL) (Figure 7).  While the mCherry fluorescence re-
localized to the nucleus (Figure 7A upper panel; Figure 7B red trace), no change was 
seen in the localization of the erControl-Cerulean reporter (Figure 7A lower panel, 7B 
blue trace).  Therefore, in both the pmDEVD and the erDEVD reporters, the linker region 
was responsible for the re-localization of the fluorophore during induction of apoptosis.  
Similar results were observed in cells treated with STS (2µM) (data not shown).  
Notably, the erDEVD reporter does not completely relocalize from the ER to the cytosol 
after caspase activation.  This could indicate that the reporter is inaccessible at the plasma 
46 
 
membrane.  Inaccessibility could also be an issue of the pmDEVD reporter, but would 
not be detectable owing to the cytosolic (and not nuclear) relocalization which would 
mask the presence of some plasma membrane fluorescence. 
 
 
Figure 6: Time lapse images and quantification of the pmDEVD reporter in 
widefield microscopy.  (A) pmDEVD-mCherry expressed in HeLa cells and treated 
with 2μM of STS.  Caspase activation is indicated by an increase in total 
fluorescence.  (B) Quantification of cytosolic fluorescence for the cells in (A) shows 
and increase in fluorescence of pmDEVD reporter.  Time points with squares 
correspond to the images in A. 
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Figure 7: Time lapse images and quantification of the erDEVD reporter.  (A) 
erDEVD-mCherry and erControl-mCerulean reporter expressed in the same HeLa 
cell and treated with 2μM of STS.  The erDEVD reporter relocalizes to the nucleus 
and the erControl reporter remains associated with the ER.  (B) Quantification of 
nuclear fluorescence for the cells in A shows and increase in the pmDEVD reporter 
(red diamonds), but no significant change in the pmControl reporter (blue 
triangles).  Time points with squares correspond to the images in A. 
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Comparison to Existing Reporters 
We next compared the developed re-localization reporters to existing reporters on 
the basis of signal strength and kinetic sensitivity.  One existing reporter has a caspase-
3/7 targeted DEVD linker between two fluorophores and yields a change of FRET upon 
caspase activity (FRET-DEVD) (Nguyen and Daugherty, 2005).  This reporter consist of 
the fluorophores CyPet and yPet which were optimized FRET fluorophores derived from 
CFP and YFP respectively (Nguyen and Daugherty, 2005).  A second existing reporter 
has a fluorescent protein and a nuclear localization signal (NLS) which are separated by 
DEVD linker from a nuclear export signal (NES).  This reporter localizes to the nucleus 
upon activation of caspase-3/7 and removal of the nuclear export signal (pCaspase-3 
sensor, Clontech).   
 
To compare the signal strength properties of the reporters, we monitored both the 
fold increase of the signal of the reporters in different cells, and determined the ratio of 
magnitude of the increase relative to the noise of the initial signal (n>10 cells).  The fold 
increase of the pmDEVD reporter (4.5±1.9) was similar to the erDEVD reporter 
(4.2±1.5), but was significantly greater than the increase of the pCaspase-3 and FRET 
reporters (2.2±0.7, p=0.003, and 2.4±0.4, p=0.0006 respectively) (Figure 8).   
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Figure 8: Comparison of the fold increase properties of the different reporters.  The 
pmDEVD reporter shows the largest fold increase, and the erDEVD reporter is 
within error.  By comparison the pCaspase-3 sensor and the FRET sensor show less 
of an increase (p=0.003 and p=0.0006 respectively).  All error bars represent 
standard deviation. 
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We next wanted to assess the signal to noise ratio of the reporter which gives an 
approximate measure of the dynamic range of the reporter.  The signal to noise is defined 
as the increase in fluorescence divided by the standard deviation of the reporter signal 
prior to caspase activation (Figure 9A).  The pmDEVD has the highest ratio (80±50), and 
erDEVD has the second lowest ratio (65±34). The ratios of the pCaspase-3 sensor and the 
FRET-DEVD (39±9, and 22±11 respectively) reporter are significantly smaller than the 
pmDEVD ratio (P=0.009 and P=0.0007 respectively) (Figure 9B).  Thus in comparing 
the reporters on their fold increase an in the signal to noise ratio, the pmDEVD reporter 
showed better signal strength than the pCaspase-3 sensor and the FRET reporter. 
The reporters were next compared based on the kinetics of their response: 
specifically the time of the first detectable signal of the reporters, and the time to the half-
maximum point of the activity curves.  The first detectable signal was quantified as the 
time when the signal was two standard deviations above the noise of the basal signal.  In 
all cases we made kinetic comparisons between different reporters expressed 
simultaneously in the same cell, to avoid potential variability between cells.  Possible 
variability could result from the amount of caspase present in different cells or the degree 
of caspase activation from cell to cell. We induced apoptosis in cells transfected with 
both the pmDEVD and FRET-DEVD reporter, or in cells expressing the pmDEVD, 
erDEVD and pCaspase-3 reporters simultaneously and quantified the signal of each.  
Example kinetic traces of the simultaneous use of these reporters are shown in Figure 10.   
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Figure 9: Comparison of the signal to noise of the different reporters.  (A) Signal to 
noise is calculated as the standard deviation of the ten points before caspase 
activation divided by the fold increase. (E) Comparison of signal to noise for the 
different reporters. The pmDEVD has the highest ratio (80±50), and erDEVD has 
the second lowest ratio (65±34). The ratios of the pCaspase-3 sensor and the FRET-
DEVD (39±9, and 22±11 respectively) reporter are significantly smaller than the 
pmDEVD ratio (p=0.009 and p=0.0007 respectively). 
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Figure 10: Comparison of the different reporters in the same cell.  To check the 
differences in the kinetics of the reporters we made comparisons of reporters in the 
same cell.  (A) Kinetics of a pmDEVD (red triangles) and FRET-DEVD (yellow 
circles) reporter in the same cell.  The reporters show similar kinetics.  (B) Kinetics 
of the pmDEVD (red triangles), erDEVD (yellow squares) and pCaspase-3 (blue 
circles) reporters expressed in the same cell shows slightly differences in kinetics of 
the reporters. 
 
 
53 
 
 
Figure 10 
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The first detectable caspase activation signal was consistently observed with the 
pmDEVD reporter (Figure 11).  We therefore made comparisons of the pmDEVD 
reporter to each of the other reporters.  There was a time lag between the pmDEVD and 
the erDEVD reporter (100±41s for first detectable signal, and 247±118s to half-
maximum activation).  The pCaspase-3 sensors were significantly delayed relative to the 
pmDEVD reporter (delay to first detectable signal = 154±80s, delay to half-maximum = 
186±133s). For the FRET-DEVD reporter the delay to the first detectable signal 
(31.9±88s) or to half-maximum (141±169s) was not statistically significant.  Therefore, 
the pmDEVD reporter preserves the kinetic properties of the FRET-DEVD reporter, 
while only using a single fluorophore, and having a larger fold increase in the signal. 
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Figure 11: Quantification of the kinetic properties of the different reporters,  (A) 
The first detectable signal of the pmDEVD reporter was observed before the 
erDEVD reporter (100±41seconds), the  pCaspase-3 sensor (154±80 seconds), and at 
the same time as the FRET reporter (31.9±88 seconds).  (B) The pmDEVD reporter 
reached the half-maximum faster than the erDEVD reporter (247±118 seconds), the 
pCaspase-3 sensor (186±133 seconds). For the FRET-DEVD reporter the delay to 
half-maximum (141±169 seconds) was not statistically significant.  All error bars 
represent standard deviation. 
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To determine that the release of the reporter coincides with other apoptotic events, 
we monitored the release of cytochrome c-GFP along with the pmDEVD reporter.  
Observations of the release of mitochondrial proteins suggest that caspase activation 
occurs approximately 10 minutes before caspase activation (Rehm et al., 2003).  We 
expressed the pmDEVD-mCherry reporter in HeLa cells along with cytochrome c-GFP 
and induced apoptosis with 2μM of STS.  Cytochrome c release from mitochondria 
occurred before the detected pmDEVD caspase activation (Figure 12A).  We quantified 
the release of cytochrome c release by monitoring the standard deviation of the pixels 
divided by the total intensity (referred to as the punctuate diffuse index) (Figure 12B).  
Thus when cytochrome c is aggregated in mitochondria, the standard deviation should be 
high, and when released, the standard deviation should decrease.  This quantification also 
demonstrated cytochrome c-GFP release occurred a few minutes before caspase 
activation (Figure 12B).   
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Figure 12: Release of cytochrome c-GFP and pmDEVD-mCherry in the same cell.  
HeLa cells treated with 2µM STS.  (A) Images of cytochrome c release (top panel) 
and caspase activation (lower panel).  (B) Quantification of the release of 
cytochrome c-GFP (green) measured as the standard deviation/total intensity of the 
cell, and cytosolic mCherry fluorescence (red). Squares indicate data points 
corresponding to the images in A. 
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Effect of pmDEVD on the Progression of Apoptosis 
A potential concern with any reporter is that it might perturb the event that it is 
designed to assay.  To determine whether the expression of the pmDEVD reporter, which 
is a caspase-3 and -7 target, would affect the progression of apoptosis, we assayed 
whether expression of pmDEVD delayed chromatin condensation – an event downstream 
of caspase-3/7 activation (Liu et al., 1997).  Cells were transiently transfected with the 
pmDEVD reporter, treated with STS (2µM), fixed at different time points, and were 
stained with TUNEL – which marks apoptotic cells.  Expression of the pmDEVD 
reporter had no detectable effect on the kinetics of TUNEL staining (Figure 13).  This 
result illustrates that the pmDEVD reporter records the kinetics of caspase-3/7 activation 
without a detectable effect on subsequent apoptotic steps. 
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Figure 13: Test of potential effects of the pmDEVD reporter on DNA fragmentation. 
Cells were transiently transfected with the pmDEVD reporter, treated with 
staurosporine (2µM), fixed at different time points, and were stained with TUNEL. 
Percentage of dead cells transfected with pmDEVD-mCherry (red square); 
Percentage of dead untransfected cells (yellow circle).  Each data point represents 
the average from three wells − with >50 cells analyzed per well. 
 
Summary 
 We created two reporters for assaying caspase activity in single cells.  One 
of the reporters relocalizes from the plasma membrane to the cytosol (pmDEVD), and the 
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other reporter relocalizes from the ER to the nucleus (erDEVD) (Figure 3,4).  Each 
reporter requires the use of only a single fluorophore, and is genetically encoded which 
enables use in organisms and the creation of stable cell lines.  In comparing the signal 
strength and kinetic properties of each of the reporters, we find that the pmDEVD 
reporter had similar kinetic properties to the FRET reporter, but showed a greater signal 
increase (Figures 8-11).  We also demonstrate that the pmDEVD reporter can be 
monitored with confocal or widefield microscopy in single cells (Figures 5,6).  This 
probe reports activity after cytochrome c release which is consistent with existing data, 
and does not have an effect on DNA fragmentation (as assayed by TUNEL staining) 
which is downstream of caspase activity (Figure 13).  This suggests that the pmDEVD 
reporter assays caspase activity without noticeably affect the progression of apoptosis. 
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Chapter Three: Similarity of Sister Cell Apoptosis 
Introduction 
Cells destined to undergo apoptosis in response to internal
 
stresses and some 
external stresses release cytochrome c and
 
Smac from mitochondria (Ow et al., 2008), 
and within minutes
 
activate caspase-3 and caspase-9 (Rehm et al., 2003). In contrast
 
to 
the tight timing between these events, the duration of events following exposure to an 
apoptotic agent but preceding cytochrome c release and caspase activation can vary
 
from 
1 hour to over 20 hours within a clonal population of cells
 
(Goldstein et al., 2000). This 
variation is striking considering
 
that the biochemical events within this delayed and 
variable
 
stage determine whether the cell will die or survive.
 
 
Population variability has also been documented for other phenotypes,
 
including 
phage lambda infection (Arkin et al., 1998), bacterial
 
chemotaxis (Spudich and Koshland, 
Jr., 1976), cell differentiation
 
 (Abkowitz et al., 1996; Enver et al., 1998) and HIV-1 Tat 
transactivation (Weinberger et al., 2005).  Understanding the sources and dynamics
 
of 
apoptotic variability can lend insight into the precision
 
with which cells are able to 
process extracellular signals.
 
A number of different factors could contribute to population
 
variability of apoptosis, including differences in the composition
 
of single cells, the local 
environment of single cells, or stochasticity
 
in biochemical reactions triggered by 
apoptotic stimuli.
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Here, we observe
 
that when and whether cells entered apoptosis were 
synchronized
 
between cells in close proximity. Entry into apoptosis did not
 
correlate with 
the distance between unrelated cells, or with
 
the phase of the cell cycle. Entry into 
apoptosis was strongly
 
correlated for sister cells, and this correlation diverged over
 
subsequent generations. The divergence of apoptosis times was
 
inhibited by blockade of 
protein synthesis. These results indicate
 
that there is a persistent cellular state underlying 
the susceptibility
 
of a single cell to apoptosis.  These results are similar to a separate 
study published while our work was in review (Spencer et al., 2009). 
 
Results 
Neighboring Apoptosis 
To gain insight into the cell-to-cell variability in the onset of apoptosis, we 
developed HeLa cell lines that stably expressed the pmDEVD-mCherry caspase-3/7 
reporter and a nuclear marker (YFP-NLS) to facilitate cell tracking.  Using wide-field 
microscopy, we monitored cellular fluorescence in cells that were plated 40 hours prior to 
treatment with STS (2µM).  Cells were imaged every 5 minutes with a 10x objective 
using an Olympus IX81 widefield microscope.  The onset of caspase-3/7 activation was 
indicated by a large increase in cellular fluorescence of pmDEVD-mCherry when 
observed by wide-field microscopy (Figure 14A: mCherry false colored green, YFP-NLS 
false colored blue). A map of nuclei which are color coded to represent the time of 
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caspase-3/7 activation indicates that groups of spatially clustered cells undergo apoptosis 
at similar times, and thus a localized synchronization of apoptosis (Figure 14B).   
 
To quantify the local synchronization of caspase-3/7 activation observed in Figure 
14 for all pairs of cells we plotted the difference in the time of caspase-3/7 activation as a 
function of the distance between cells.  When cells were closer to each other it was more 
likely that their caspase activation would be synchronized (Figure 15C - blue).  To 
determine potential artifacts of the analysis that could generate a spatial correlation, we 
randomly reassigned apoptosis times to different cellular positions and no correlation was 
reported, thus demonstrating that the analysis did not contribute to the spatial correlation 
between caspase-3/7 activation and intercellular distance (Figure 15C - red).  
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Figure 14: Local synchronization of apoptosis. (A) HeLa cells expressing pmDEVD-
mCherry (green) and YFP-NLS (blue) treated with 2μM of STS.  Onset of DEVDase 
activation is marked by the increase in fluorescence.  (B) Nuclei of HeLa cells in A. 
Nuclei are color coded to represent the times of apoptosis. Clusters of cells with 
white outlines indicate examples of neighboring cells undergoing DEVDase 
activation at similar times. 
65 
 
 
 
 
Figure 14 
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Figure 15: Plot of the difference in time of apoptosis between HeLa cells as a 
function of their distance reveals a correlation between apoptosis and distance. 
(Error bars represent 95% confidence interval of the mean.) 
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The following are three possibilities that could explain the correlation of the 
distance between cells and the time of caspase activation:  First, cells that are near each 
other may be sister cells which are at a similar phase of the cell cycle. If there is a cell 
cycle dependant susceptibility to apoptosis this could account for the local 
synchronization of the activation of caspases.  Second, cells may secrete factors that 
promote or hinder apoptosis in a local neighborhood.  Third, sister cells may have similar 
molecular compositions uncoupled from the cell cycle that affects their sensitivity to 
entering apoptosis. 
 
Cell Cycle and Apoptosis Correlation 
To investigate the role of the cell cycle in locally synchronized apoptosis, we 
monitored fluorescent reporters for both apoptosis and the cell cycle stage in single cells.  
Two approaches were taken.  The first was to synchronize the cell cycle.  HeLa cells 
expressing pmDEVD were subjected to a double thymidine block (15 hr block, 10 hr 
release, 15 hr block), and released for variable intervals before treatment with STS 
(2µM).  No correlation was observed between the time to apoptosis and the time cells 
were treated after release (One way ANOVA: F=1.26 < Fcrit=2.40; Figure 16).   
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Figure 16: Cell Cycle Synchronization Experiment. HeLa cells expressing pmDEVD 
were subjected to a double thymidine block (15 hour block, 10 hour release, 15 hour 
block), and released for variable intervals before treatment with 2 µM STS. No 
correlation was observed between apoptosis and the time cells were treated after 
release. One way ANOVA performed to determine significant differences between 
apoptosis at different time points. F=1.26<Fcrit=2.40; therefore there is no 
significant difference between inducing apoptosis at different times after release 
from a double thymidine block. 
 
One potential concern of the cell cycle synchronization experiment is the effect of 
cell cycle synchronizing agents on apoptosis (Ji et al., 1997), which might mask a cell 
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cycle sensitivity.  Thus, the second approach was to observe an asynchronous population 
in which the state of the cell cycle could be characterized in each individual cell with a 
fluorescent reporter.  For this purpose we observed the G1/S cell cycle transition using a 
fluorescent fusion to the PSLD domain of human DNA Helicase B (referred to as PSLD-
mCitrine) (Gu et al., 2004; Taneja et al., 2002).  This PSLD-mCitrine reporter is localized 
to the nucleus in G1 phase and transitions to the cytosol upon cyclinE CDK 
phosphorylation, which marks the G1/S transition (Gu et al., 2004) (Figure 17) .   
 
 
Figure 17: PSLD-mCitrine cell cycle reporter.  This reporter transitions out of the 
nucleus owing to cyclin E-CDK2 phosphorylation at the G1/S transition.  It begins 
in the nucleus in G1 phase , then transitions to being in both the nucleus and the 
cytoplasm during the G1/S transition, and the reporter becomes cytosolic in the 
S/G2 phase. 
 
To facilitate identifying and tracking individual cells we used a Cerulean-NLS as 
a nuclear marker.  The nuclear fluorescence was determined by tracking Cerulean-NLS 
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using the Spot Module in Imaris. A mask of the Cerulean NLS fluorescence was created 
and the PSLD-mCitrine fluorescence was monitored in that mask.  An example of the 
quantification of PSLD-Citrine nuclear fluorescence is shown in Figure 18 A and B.  
Here a mother cell (green trace) divides into two daughter cells (blue and red trace), both 
of which undergo the G1-S transition.  At time t=1.8 hours the mother cell enters M 
phase − the fluorescence associated with the nuclear marker increases owing to a 
breakdown of the nucleus and rounding of the cell. The cell divides at time t=3.5 hours, 
and later at approximately t=9 hours, the cells start to undergo the G1-S transition, 
resulting in a decrease of nuclear fluorescence.  The duration of G1 phase was 
determined by the time difference between division, and the decrease in nuclear 
fluorescence of the PSLD-Citrine. A histogram was created for n=143 cells. The duration 
is 4.7±2.3 hours (standard deviation) indicating considerable variability in the duration of 
G1 (Figure 18C).   
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Figure 18: Quantification of the PSLD cell cycle reporter.  (A) The PSLD-mCitrine 
nuclear fluorescence of the mother cell is indicated by the green line; the nuclear 
fluorescence of the daughter cells is indicated by the red and blue lines. At time 
t=1.8 hours the mother cell enters M phase and the cell divides at time t=3.5 hours. 
At approximately t=9 hours, the cells start to undergo the G1-S transition, resulting 
in a decrease of nuclear fluorescence. (B) Fluorescence images corresponding to the 
quantification in A.  (C) The duration of G1 phase was determined by the time 
difference between division, and the decrease in nuclear fluorescence of the PSLD-
Citrine. A histogram was created for n=143 cells. The duration is 4.7±2.3 hours 
(standard deviation) indicating considerable variability in the duration of G1. 
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To monitor both the stage of the cell cycle and the onset of caspase activation we 
co-expressed Cerulean-NLS, PSLD-Citrine and pmDEVD in HeLa cells and treated cells 
with 2 µM STS (Figure 19). Here, the nuclear outline in the upper panel indicates the 
mask created by the Cerulean-NLS fluorescence.  We tracked cells for several hours prior 
to the addition of STS (time t=0 indicates when STS is added). The activation of caspase-
3/7 is indicated by an increase in fluorescence (Figure 19 – lower panel).  
 
 
 
Figure 19: Monitoring the cell cycle and caspase activity in the same cell. (Top 
Panel) Expression of the PSLD-mCitrine cell cycle reporter.  Cells transition out of 
G1 (nuclear to cytosolic localization).  (Bottom Panel)  Caspase activity of the 
pmDEVD mCherry reporter indicated by the increase in fluorescence. 
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The phase of the cell cycle was determined relative to either the G1/S transition, 
or the time of last division.  The time of apoptosis was plotted as a function of the 
position in the cell cycle at the time of STS treatment since the reporter becomes 
localized in both the nucleus and cytoplasm after STS treatment.  No correlation could be 
detected between the phase of the cell cycle at the time of STS addition, and the time of 
caspase activation after treatment with STS (Figure 20).  These results indicate that the 
correlation of the distance between cells and when cells enter apoptosis in response to 
STS is not related to the cell cycle. 
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Figure 20:  Correlation of the stage of the cell cycle and the onset of caspase 
activation in single cells.  HeLa cells expressing the PSLD-mCitrine reporter and the 
pmDEVD-mCherry reporter were monitored to determine the stage of the cell cycle, 
then treated with 2μM of STS.  There was no clear correlation between the phase of 
the cell cycle at the time of treatment and the time to caspase activation. 
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Separation of Distance and Genealogy 
To determine if the local synchronization in activation of caspases was the effect 
of secreted factors or of a similarity of molecular composition of sister cells, we 
performed three different tests.  The first test was to monitor the activation of caspase in 
the rapidly moving HT1080 cell line that was stably expressing pmDEVD-mCherry and 
YFP-NLS.  HT1080 migrate after division such that average distance between nuclei of 
sister cells was 223±39 µm (compared to 66±13 µm for HeLa pairs; Figure 21).  In the 
HT1080 cells there is a lower probability that neighboring cells are also sister cells which 
would uncouple effects of possible secreted factors from similarities in the molecular 
composition of the cell.  The rapid movement also created situations where a pair of sister 
cells were separated by an unrelated cell.  In these situations we determined whether the 
time of caspase activation in each sister cell was correlated with the nearer unrelated cell 
or the more distant sister cell.   
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Figure 21: Distance correlation for the HT1080 cell line. (A) A histogram of the 
distance between sister cells at the time of drug treatment indicates that the distance 
between HT1080 sister cell pairs is larger than the distance between HeLa cell pairs. 
The average distances are 223±39 µm for HT1080 cells, and 66±13 µm for HeLa 
cells. 
 
An example of HT1080 sister cells that are separated by other cells at the time of 
STS (2μM) treatment is shown in Figure 22A.  While the sister cell pair undergo 
apoptosis at similar times, a cell that had migrated so that it was between the sister cells 
does not undergo apoptosis until much later (Figure 22B).   
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Figure 22: (A) Time lapse images of HT1080 cells before and after treatment with 
STS. T=0:00 indicates the time of STS addition. HT1080 cells express the pmDEVD 
caspase-3/caspase-7 reporter (grey-scale), and YFP-NLS (shown as a colored 
nuclear outline). An instance of sister cells that are physically separated is indicated 
by cells with a red nuclear outlines. The separating cell is indicated with a yellow 
nuclear outline. All other nuclei are in blue. (B) Time course of caspase-3/caspase-7 
activation of the sister cells in (A), and a cell between the sister cells. Color of the 
data points corresponds to cells with the same colored nuclear outline in (B). Cells 
undergo apoptosis at a similar time relative to the distribution of apoptosis, and 
relative to the middle cell. 
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Figure 22 
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Furthermore, for HT1080 cells, there was no correlation between inter-cellular 
distance and the onset of apoptosis (Figure 23).  This suggests that a secreted factor 
cannot be entirely responsible for the correlation between caspase activation and distance.  
However this does not exclude the partial contribution of secreted factors to the 
correlation seen in HeLa cells (Figure 14). 
 
 
Figure 23: Plot of the difference in time of apoptosis between HT1080 cells as a 
function of their distance. (n=195 cells in three fields). Error bars represent 95% 
confidence interval of the mean. 
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The second test was to uncouple distance and genealogy by dissociating cells 
from their dish, and then re-plating them so their positions are randomized (Figure 24).  If 
the genealogical relationship between cells was responsible for the local synchronization 
of apoptosis, then when cells were dissociated and then re-plated at a high density, the 
local effects should be lost.  In contrast, effects of secreted factors on neighboring 
apoptosis should be unaffected. 
 
Figure 24: Scheme of plating experiments.  Cells in which apoptosis is induced 
shortly after plating are unlikely to be related; by comparison cells that are treated 
with a drug long after plating are more likely to have divided and thus be related.  
Cells of similar colors are related cells. 
 
Cells that were plated 48 hours or 80 hours prior to STS treatment showed a 
strong distance correlation (Figure 25): The delay between two cells entering apoptosis 
that were 50 µm apart was 24% less than cells 200 µm apart for cells plated 48 hours 
prior to treatment.  However, for cells plated 14 hours prior to STS treatment, the 
decrease in the delay for entering apoptosis for cells at a distance of 50 µm was reduced 
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only 8%, indicating a weaker local effect. This residual degree of synchronization could 
be due to the presence of a few neighboring sister cells which divided within 14 hours 
after plating (data not shown).   
 
Figure 25: Analysis of time difference of DEVDase activation as a function of 
distance for cells plated at various times prior to STS addition (number of cells>385 
for each time point). 
 
The third test was to separate the effects of HeLa cell genealogy and inter-cell 
distance by determining the correlation between caspase-3/7 activation and distance after 
excluding comparisons between related HeLa cells.  Cells at closer distances demonstrate 
a higher similarity of their times of caspase-3/7 activation than cells further apart 
indicating a correlation between caspase-3/7 activation and distance (Figure 26 - red).  
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However, when sister cells were excluded from the comparison the correlation was 
weaker (Figure 26 - green) and further weakened when sister and cousin cells are 
excluded (Figure 26 - purple).  To determine whether the spatial correlation to apoptosis 
was only between sister cells, we plotted time of caspase-3/7 activation between sister 
cells as a function of their inter-cell distance (Figure 26 - blue). While these showed a 
high degree of similarity between time of entering apoptosis, they did not show 
correlation with distance.  The lack of spatial correlation between sister cells further 
indicates that a secreted factor between sister cells does not contribute to the correlation 
between caspase activation and intercellular distance.  The combination of the above 
experiments suggests that secreted factors do not play a role that we can detect in the 
local synchronization in the activation of caspases. 
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Figure 26: Analysis of the time difference of DEVDase activation as a function of 
distance between cells for sister cell cells (blue), between all cells (red), between all 
cells that are not sister cells (green), and between all cells that are not sister cells or 
cousin cells (purple) (n=562 cells in three fields). 
 
Similarity of Apoptosis Timing Between Sister Cells 
The observation that in unrelated cells there is no correlation between distance 
and when cell undergoes apoptosis implicates cell lineage and an underlying source for 
the local synchrony of apoptosis.  This was further tested by quantifying the difference in 
caspase activation between sister cells (Figure 27 - blue).   As a control we measured the 
distribution of the differences in the time of caspase activation between randomly paired 
cells (Figure 27 – red). When HeLa cells were treated with STS (2µM), the difference in 
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caspase-3/7 activation between randomly paired cells was significantly greater than the 
difference in caspase-3/7 activation between sister cells (p=6.2x10
-34
; Figure 27).  This is 
an independent confirmation of the role of lineage in determining when a cell undergoes 
apoptosis. 
 
 
Figure 27: Histogram of the difference in time of DEVDase activation between HeLa 
sister cells, and between randomly paired cells (n=265 pairs). 
 
To determine whether the similarity in apoptosis times between sister cells was 
specific to a cell type or apoptotic stimuli, we calculated the average difference in the 
onset of caspase-3/7 activation between sister cells, and between randomly paired cells 
for HeLa, NIH3T3, HT1080, and mouse embryonic fibroblasts (MEF) cells.  These cells 
were treated with STS (2μM), TNFα (250μg.mL) + CHX (5μg/mL), or etoposide (ETO, 
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50μM) (Figure 28).  In all cases the average time difference of caspase-3/7 activation 
between sister cells was significantly less than the average time difference of caspase-3/7 
activation between randomly paired cells.  These results, obtained in multiple cell types 
and with multiple drugs, indicate that the similarity of caspase-3/7 activity between sister 
cells is not a cell type specific or drug-specific effect. 
 
 
Figure 28: Average difference in DEVDase activation between sister cells (blue), and 
randomly paired cells (red) for HeLa, NIH3T3 and HT1080 cells treated with 2 µM 
STS, 250 ng/µl TNF  + 5 µg/ml CHX, or 50 µM ETO. Differences between sister 
and random distributions are significant for all cell types (STS: HeLa, P=6.2x10
–34
; 
3T3, P=0.0011; HT1080, P=2.1x10
–10
; MEF, P=9.9x10
–4
. TNF +CHX: HeLa, 
P=1.4x10
–16
; 3T3, P=4.7x10
–14
; HT1080, P=5.8x10
–10
. ETO: HeLa, P=1.2x10
–11
. For 
MEFs, npairs=21; for all other cells: npairs is between 54-106 pairs for different 
conditions). 
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Similarity of Sister Cell Fate 
To determine whether the cellular fate was similar between sister cells, we used a 
milder apoptotic treatment which only killed a fraction of cells, and determined whether 
both sister cells underwent apoptosis or survived, or whether only one of the sister cells 
underwent apoptosis.  HeLa cells were transiently treated with of STS (1µM) for 45 
minutes, and during the subsequent 36 hours, 44% of the cells underwent apoptosis.  If 
there was no linkage in the fate between sister cells, then of 72 total cell pairs, 14 pairs 
should both undergo apoptosis, 22 pairs should both survive, and 36 pairs should have 
only one cell undergoing apoptosis (Figure 29 - red).  Instead we observed that 27 sister 
pairs both underwent apoptosis, 35 pairs both survived, and there were 10 pairs where 
only one cell underwent apoptosis (Figure 29 - blue).  Of the cells that did not undergo 
apoptosis, a few did not divide again, and it is possible that even 36 hours after treatment, 
apoptosis will still continue to occur.  Nonetheless, given that 44% of all cells die, the 
probability that there are only 10 pairs of sister cells of which only one undergoes 
apoptosis is p<0.0005 (
2
= 37.2, 2 degrees of freedom).  This indicates that not only the 
timing of apoptosis between sister cells is similar (Figure 27), but also when given a mild 
apoptotic treatment, the fates of sister cells are similar (Figure 29).  
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Figure 29: HeLa cells treated with 1 µM STS for 45 minutes. In blue are counts of 
sister cell pairs where both cells die, only one cell dies and where both survive. In 
red is the expected value of the counts if there were no apoptosis similarity between 
sister cells, and given that 44% of all cells underwent apoptosis. All error bars 
represent the 95% confidence interval of the mean. 
 
Intergenerational Divergence of the Apoptosis Susceptibility 
The similarity of the apoptosis between related cells could be stable – resulting 
from the inheritance of genes.  Thus the similarity of whether and when related cells 
undergo apoptosis could result from the presence of a mixture of difference cell lineages.  
However, the similarity could also be transient – arising from the division of proteins 
from the mother cell.  Alternatively, the similarity may be a combination of these factors.  
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To distinguish between these possibilities, we monitored the lineage of cells up to four 
generations prior to apoptosis treatment.  We reasoned that if the similarity resulted from 
a temporary inheritance of proteins, then the difference in the time of caspase-3/7 
activation between two cells should become larger as the cells are more distantly related.  
Alternatively, if it were a stable genetic alternation, then the differences in the time of 
caspase activation should remain constant for the different lineages.  To assay differences 
and similarities in apoptosis susceptibility for a time longer than four generations, we 
created clonal cell lines and compared the distribution of the time of caspase-3/7 
activation between these lines.  If similarity of apoptotic state resulted from a stable 
genetic inheritance, we expected a significant difference in the time of caspase-3/7 
activation between different cell lines.  We monitored cells for up to 90 hours prior to 
apoptosis treatment to determine the lineage of cells.  We defined sister cells as being one 
generation apart and cousin cells as being two generations apart (Figure 30).   
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Figure 30: Lineage of cells.  We monitored cells for up to 90 hours prior to apoptosis 
treatment to determine the lineage of cells.  We defined sister cells as being one 
generation apart and cousin cells as being two generations apart. 
 
After monitoring the lineage of HeLa cells for four generations, we treated cells 
with STS (1 µM) and compared the time of apoptosis between cells that shared a 
common ancestor (Figure 31).  A histogram of the apoptosis time differences, as well as 
the apoptosis time difference between randomly paired cells is shown in Figure 31.  As 
the relation between cells becomes more distant (from gold, to green to blue to red), the 
histogram flattens, approaching the histogram of randomly paired cells (Figure 31). 
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Figure 31: Divergence of apoptotic susceptibility. (A) The difference in time of 
apoptosis between cells from different generations. As the number of generations 
between cells increases, the curve flattens. 
 
To determine the dynamics of the divergence of the apoptotic susceptibility, we 
fit the mean difference of the time to enter apoptosis between cells from different 
generations to an exponential recovery curve (Figure 32).  This curve was selected on the 
assumption that cells lost a proportional fraction of their apoptotic susceptibility during 
division or over time.  The fit was of the form y=42.5+43.2(1–e–(g–1)/1.94) with y minutes, 
and g in generational difference between cells.  Analysis of the fitted parameters revealed 
that the half-time of loss of apoptosis susceptibility was 1.3±0.6 generations, and as cells 
become more distantly related, the difference in their time of apoptosis approaches the 
asymptote of 86±9 minutes.  The calculated half-time is similar to half-times of the 
mixing of gene expression in related mammalian cells (Sigal et al., 2006b), suggesting 
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that the similar apoptosis times of sister cells may reflect the similarity of gene 
expression levels.  Furthermore, the calculated time of apoptosis between distantly 
related cells (86±9 min) is within error of the measured apoptosis time differences 
between unrelated cells (90±1 min), indicating that the similarity of the apoptotic state of 
related cells is transient, and does not result from genetic differences. 
 
 
Figure 32: Analysis of the difference in DEVDase activation between cells from 
different generations and between unrelated cells (blue circles). Cells are fit to an 
exponential recovery curve (solid red line). Exponential fit is: y=42.5+43.2(1–e–(g–
1)/1.94
) with y minutes, and g in generational difference between cells; R
2
=0.988 for 
the shown data points. Red dotted line is the asymptote of exponential recovery fit. 
Pink overlay is the error of the asymptote. 
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To examine the persistence of apoptosis susceptibility over more than four 
generations, we analyzed the distributions of the onset of caspase-3/7 activation in clonal 
cell lines (Figure 33).  The overlap in the distributions was significant (One way 
ANOVA: F=1.29, Fcrit=2.38, F>Fcrit) indicating that the similarity in apoptosis 
susceptibility does not persist indefinitely, and is unlikely a result of genetic variation or 
the presence of multiple cell lineages. 
 
 
Figure 33: Kinetics of apoptosis in clonal populations.  Clonal cells expressing the 
pmDEVD-mCherry reporter treated with 2 μM STS.  Overall distribution of 
apoptosis was similar according to One Way ANOVA. 
93 
 
 
Intragenerational Apoptosis Divergence 
To gain insight into the divergence of apoptosis susceptibility, we plotted the 
difference in caspase activation as a function of the time since sister cells or cousin cells 
divided from their last common ancestor (Figure 34).  An exponential recovery curve was 
fit to the data; this was of the form: y=5.8+68.5(1–e–t/1256).  To assess intragenerational 
trends, cell pairs were binned according to the time since division (500 minute bins; 
Figure 34).  We found that apoptosis times between newly divided sister cells was more 
similar than sister cells that had divided long before STS treatment (1μM STS – Figure 
34).  Thus, the varied susceptibility to apoptosis is a function of the time that cells spend 
apart.  These results indicate that the loss of correlation of apoptosis between sister cells 
occurs continuously and not as a discrete step during mitosis, or another phase of the cell 
cycle.   
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Figure 34: Difference in DEVDase activation between related cells (sister cells, 
green; cousin cells, red) as a function of time since cells shared a common ancestor. 
Recovering exponential fit (blue line), confidence interval of fit (yellow line) are 
plotted as well as individual time points from a 500 minute binning (black squares). 
Exponential fit is: y=5.8+68.5(1–e–t/1256) with y and t in minutes; R2=0.122. 
 
Inhibition of Divergence 
One possibility for the divergence of apoptosis susceptibility in sister cells is a 
difference in gene expression after division.  To determine whether new protein 
expression was responsible for the divergence of apoptosis susceptibility, we inhibited 
protein expression in newly divided cells using cycloheximide (CHX) - an inhibitor of 
protein translation (ENNIS and LUBIN, 1964; SIEGEL and SISLER, 1963).  We sought 
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to inhibit protein synthesis prior to apoptosis treatment but after cell division, Thus in an 
asynchronous culture we monitored newly divided HeLa cells under the following 
conditions: (1) in the presence of CHX (20 µg/mL) for 9 hours, (2) in the absence of 
CHX for 3 hours, followed by the presence of CHX for 6 hours, (3) in the absence of 
CHX for 6 hours, followed by the presence of CHX for 3 hours, and (4) in the absence of 
CHX for 9 hours.  Cells were then treated with CHX (20 µg/mL) and STS (1µM) (Figure 
35).   
 
Figure 35: Schematic of the protein inhibition experiment.  (1) in the presence of 
CHX (20 µg/mL) for 9 hours, (2) in the absence of CHX for 3 hours, followed by the 
presence of CHX for 6 hours, (3) in the absence of CHX for 6 hours, followed by the 
presence of CHX for 3 hours, and (4) in the absence of CHX for 9 hours.  Cells were 
then treated with CHX (20 µg/mL) and STS (1µM) 
The difference in apoptosis times was determined for sister cells.  We plotted the 
histograms of the time difference of apoptosis between sister cells.  The longer time that 
sister cells spent in the absence of CHX, the greater the difference in apoptosis times 
(Figure 36A,B).  The difference in sister cell apoptosis times for different CHX 
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treatments was not a result of an overall difference in the time of apoptosis in the 
population (Figure 36C).   
 
Figure 36: Difference in DEVDase activation between newly divided sister cells for 
different treatments with cycloheximide (see text). Relative to untreated cells, the 
difference is smaller for cells in CHX for 9 hours (P=0.0039). Error bars represent 
95% confidence intervals 
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One of the concerns of using cycloheximide is that it may have a non-specific 
effect that may alter another aspect of apoptosis.  Thus we sought to inhibit protein 
synthesis with another inhibitor to determine if we got the same effect.  Similar results 
were also observed with puromycin, another inhibitor of protein synthesis that works 
through a different mechanism from cycloheximide (Traut and Monro, 1964) (Figure 37).  
We could only extend the pre-treatment of cells in puromycin to 6 hours since at 9 hours, 
some cell death started to occur without STS treatment (data not shown).  These results 
suggest that the divergence of apoptosis times between sister cells is partially a result of 
new protein expression.  
 
Summary 
In this chapter we provide experiments demonstrating that sister cells undergo 
apoptosis a few minutes apart (Figure 27).  The similarity in apoptosis times could not be 
correlated to the cell cycle (Figure 20), or the distance between cells (Figure 22-26).  
Furthermore, not only are the apoptosis times between sister cells similar, but the fates of 
sister cells are more similar that random (Figure 29).  We also find that for related cells 
that there is divergence in the times of apoptosis as cells become more unrelated (Figure 
32).  This divergence is also observed within single generations (Figure 34) and is limited 
by blocking protein synthesis after division (Figure 36).   
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Figure 37: Divergence of apoptosis times in sister cells in inhibited by puromycin. 
(A) Experiment overview. We monitored the division of sister cells in a 3 hour 
interval prior to puromycin (1 µg/ml) treatments. These newly divided cells were 
followed under three different conditions which differed in the time that cells were 
untreated with puromycin. All cells were then treated with staurosporine (STS) (1 
µM) in the presence of puromycin (1 µg/ml). The duration of the puromycin 
experiment is shorter than the cycloheximide (CHX) owing to greater cell death 
prior to STS treatment, whereas cell death is negligible in the CHX experiment 
prior to STS treatment. (B) Distributions of the difference in caspase activation of 
sister cells under the three different puromycin treatments. The distribution 
appears to flatten the longer the cells are not in the presence of puromycin. Data 
binned in 30 minute intervals. Total number of cell pairs for each treatment is 
between 32 and 37. (C) Average time of apoptosis under the three different 
puromycin conditions. Error bars represent the 95% confidence interval of the 
mean. (D) Population distribution of apoptosis times under the three different 
puromycin conditions. 
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Figure 37  
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Chapter Four: Cytochrome c is released in a wave 
 
Introduction 
Mitochondria play a central role in apoptosis, integrating signals from members of 
the Bcl-2 family (Danial and Korsmeyer, 2004), Opa and Parl (Pellegrini and Scorrano, 
2007), and many other molecules.   It has been proposed that mitochondria integrate these 
signals, resulting in changes in membrane permeability to pro-apoptotic proteins (Ow et 
al., 2008) and the fragmentation of mitochondria (ROUILLER, 1957; Zhuang et al., 
1998). 
Once released from the mitochondria, cytochrome c interacts with Apaf-1, 
resulting in the activation of caspases that in turn cleave several vital substrates, leading 
to biochemical and morphological features characteristic of apoptosis (Li et al., 1997).  
Membrane permeability to cytochrome c is considered a critical step in the progression of 
apoptosis.  Along with cytochrome c, Smac is also released into the cytosol (Munoz-
Pinedo et al., 2006). Once in the cytosol, Smac induces degradation of the inhibitor of 
apoptosis proteins (IAPs), thereby facilitating caspase activation (Du et al., 2000; 
Verhagen et al., 2000).  Around the same time, the mitochondrial intermembrane 
becomes permeable to protons, causing loss of membrane potential (ΔΨm) (Munoz-
Pinedo et al., 2006), and the mitochondria are observed to fragment and undergo changes 
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to their internal structure (Sun et al., 2007; Frezza et al., 2006).  Furthermore, the precise 
temporal order of these events is not completely resolved (Martinou and Youle, 2006; 
Lakhani et al., 2006) 
Although cytochrome c may be released in different cells at any time over a 
period of several hours, its release within a single cell is completed within several 
minutes (Goldstein et al., 2000).  Thus, one of the major barriers to imaging the dynamics 
of cytochrome c is that its onset is so variable that when imaging is done at high temporal 
resolution, fluorescent tags are usually bleached before cytochrome c is initiated.  This 
has limited the ability to resolve whether cytochrome c and Smac are released at different 
times or simultaneously (Munoz-Pinedo et al., 2006), or whether the increase in 
permeability of the outer (Waterhouse et al., 2001) or inner (Gottlieb et al., 2003) 
membrane occurs first.  
Here, we show that cytochrome c release can be initiated at one, two, or multiple 
points in a cell and then propagates across the cell.  This behavior was observed for 
apoptosis induced by a number of different drugs.  Cytochrome c release took place 
before Smac release and loss of ΔΨm, which also occurred in waves, though lagging in 
time behind cytochrome c release.  By analyzing individual mitochondria, we show that 
mitochondrial fission occurs after cytochrome c release.  Additionally, we examine the 
dynamics of cytochrome c release from single mitochondria, showing that release occurs 
in a single step from single mitochondria.  Finally, we show that the wave of cytochrome 
c release can be inhibited by thapsigargin (a blocker of the SERCA calcium pumps) but 
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not with BAPTA-AM, which buffers cytosolic calcium levels.  These observations 
indicate that the signal for mitochondria to release cytochrome c, and, in some cases, the 
commitment to apoptosis does not take place simultaneously at all mitochondria, and 
does not occur spontaneously within the cell. 
 
Results 
Wave of Cytochrome c – GFP Release in Single Cells 
Initiation of apoptosis in a population of cultured cells is asynchronous and 
distributed over several hours (Goldstein et al., 2000).  Our observations in Chapter Three 
suggest that we can approximately predict the time when a cell will undergo apoptosis 
based on when its sister cell undergoes apoptosis (Figure 27).  Furthermore, if we allow 
HeLa cells to divide on a dish for more than 40 hours, we see a local synchrony of 
apoptosis (Figure 14).  Therefore, to obtain high temporal resolution images of 
cytochrome c GFP release, we plated HeLa cells and allowed them to divide for more 
than 40 hours, then we treated cells with an apoptotic drug, imaged clusters HeLa cells 
once every 2 minutes until one cell in a field released cytochrome c-GFP.  At this point 
the acquisition rate was increased to once every 5-10 seconds to capture the release of 
cytochrome c-GFP in nearby cells that still had mitochondrial cytochrome c-GFP. 
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An example of the dynamics of cytochrome c-GFP release in HeLa cells treated 
with TNF-Related Apoptosis Inducing Ligand (TRAIL, 1 μg/mL) is shown in images 
from a time-lapse experiment (Figure 38).  The release of cytochrome c-GFP was 
initiated at one end of the cell (indicated by the arrow), and in successive frames a wave 
of cytochrome c-GFP release swept across the cell.  This continued for 90 seconds until 
cytochrome c-GFP was no longer localized to mitochondria in the cell.  This result is 
consistent with a study published while our manuscript was in review, which also showed 
a spatial release of cytochrome c (Lartigue et al., 2008). 
To determine whether the loss of cytochrome c-GFP fluorescence was a result of 
mitochondria moving out of the plane of focus, or a complete breakdown of 
mitochondria, we monitored cytochrome c-GFP simultaneously with the mitochondria 
marker mito-mCherry (Shaner et al., 2004; Rizzuto et al., 1995).  During the loss of 
localized cytochrome c-GFP fluorescence, there were no discernable changes in the mito-
mCherry fluorescence (Figure 38B).  A wave of cytochrome c-GFP release was also 
observed using confocal microscopy (Figure 39).   
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Figure 38:  Wave of cytochrome c GFP release in single cells.  (A) Cytochrome c-
GFP release shows a spatial pattern of release initiating at the arrow and 
progressing to the bottom of the cell and back to the lower portion of the nucleus. 
(B) Mito-mCherry fluorescence does not change in this time.  Note that 
mitochondrial fragmentation can be observed.  (C) Overlay of the two images with 
cytochrome c-GFP in green and mito-mCherry in red.  Time in seconds with t = 0 
indicating the time of first detectable release 
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Figure 39: Wave of cytochrome c-GFP release in HeLa cells using confocal 
microscopy.  The top right shows a wave of release starting from the bottom and 
progressing to the top of the cell.  Time in minutes:seconds. 
 
Quantification of Cytochrome c Release Waves 
The release of cytochrome c-GFP from mitochondria was quantified using the 
average intensity of GFP in regions of interest (ROIs) (Figure 40).  Each ROI may 
contain more than one mitochondria because it was not always possible to discern 
individual mitochondrion in dense or out of focus regions of the cell.  Therefore, the 
contents of ROIs are referred to as mitochondrial clusters.  Most of the mitochondria in a 
cell were included within at least one ROI (Figure 40).   
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Figure 40: A selected image before cytochrome c-GFP release demonstrating the 
ROI coverage. The circles represent the regions of interest (ROIs) chosen for 
analysis. The red circle is ROI in which the mitochondria released cytochrome c-
GFP first. Therefore, the time of cytochrome c -GFP release from this region 
defined as t = 0 and all distance measurements are made relative to this region. The 
lines represent distance measurements from the first ROI to four other ROIs. This 
measurement is made for every ROI. 
In an individual ROI over time, the average intensity of the cytochrome c-GFP 
remained constant, then dropped to the local background level within 30 seconds (Figure 
41A).  In contrast, the mito-mCherry fluorescence remained at a constant level indicating 
that movement of the mitochondria out of the ROI is not responsible for the drop in 
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cytochrome c-GFP fluorescence (Figure 41A).  In an individual cell, we observe that 
different ROI release cytochrome c-GFP at different times (Figure 41B for the cell shown 
in Figure 38).   
To quantify the wave of release, we determined the first ROI in a cell to release 
cytochrome c (Figure 40, red ROI).  The time of cytochrome c release from an ROI was 
defined as the point when the average intensity of the ROI began to decline irreversibly 
(for example see Figure 41C).  The time of release from the first ROI was set to t=0 
seconds, and all time measurements were made relative to this ROI.  We next calculated 
the distances between the first ROI to release cytochrome c, and all other ROIs (see white 
lines in Figure 40).  Finally, to represent the wave, we plotted the distance from the first 
ROI that released cytochrome c-GFP as a function of the time of ROI release (Figure 
41D).  A correlation plot of the distance of release as a function of the time of release for 
the cell shown in Figure 40 revealed a linear relationship indicating the wave like nature 
of cytochrome c release (Figure 41D).   
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Figure 41: Quantification of cytochrome c-GFP release in a single cell.  (A) The 
normalized intensity for one ROI versus time for both cytochrome c-GFP (black +) 
and mito-mCherry (gray ×). (B) Graph of cytochrome c-GFP loss from four 
separate regions.  (C) The normalized cytochrome c-GFP intensity vs. time for an 
individual ROI. The black arrow indicates the time point selected as the release of 
cytochrome c-GFP. This point is selected because the fluorescence intensity declines 
irreversibly. The grey arrow indicates a point of decline which is not selected as the 
time of release because of the subsequent recovery. (D) Plot showing the distance of 
ROIs from the first ROI to release cytochrome c as a function of time of release (t=0 
seconds for the first ROI to release cytochrome c).  This plot corresponds to the cell 
shown in Figure 40. 
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Figure 41 
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This analysis quantitatively shows that cell-wide release of cytochrome c-GFP 
from mitochondria occurs as a propagating wave.  To determine whether the wave of 
cytochrome c release is specific to a single mode of apoptosis, we observed the dynamics 
of cytochrome c release for cells treated with different agents that trigger apoptosis.  
Similar results were observed when apoptosis was induced with the death receptor ligand 
TRAIL (1 μg/mL) (Figure 38), protein kinase inhibitor staurosporine (STS, 2μM) (Figure 
42) or the DNA damage inducing drug etoposide (ETO, 50µM) (data not shown).  The 
observation of the cytochrome c release wave in multiple modes of apoptosis indicates 
that the wave is a general sub-cellular feature of apoptosis.  
 
Patterns of cytochrome c release 
In characterizing the release of cytochrome c, three different patterns of release 
were observed (Figure 42).  The first pattern is a wave initiated at a single point with the 
release of cytochrome c propagating in one direction across the cell (Figure 42A,B).  The 
second pattern is two waves initiated at different points each propagating simultaneously 
across the cell (Figure 42C,D).  The majority of cells treated with STS or ETO, and 
approximately half of cells treated with TRAIL (1 μg/mL) had a directional (one or two 
point) pattern of release (Table 3).  Waves initiating at one or two points were observed 
in cells of oblong and round morphologies, indicating that cell shape did not induce a 
significant bias to the mode of release (Figure 42A, 43).   
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The third pattern of release of cytochrome c did not appear to be spatially 
coordinated, though similar to the other patterns, the cell-wide release was complete 
within minutes (Figure 42E,F).  This could result from a wave that initiates at the top of 
the cell, furthest from the cover slip, and propagates perpendicular to the imaging plane, 
or from multiple spatially coordinated waves initiated at several points in the cell for 
which we lack the spatial and temporal sensitivity to resolve, or simply indicate an 
uncoordinated release. 
We observed all three patterns of cytochrome c release with TRAIL, STS or ETO 
induced apoptosis (Table 3), indicating that the spatial patterns of release are not 
restricted to a single apoptotic paradigm.  Furthermore, the wave of cytochrome c release 
was also observed in murine melanoma B16F0 cells (data not shown), demonstrating that 
the wave phenomena is not restricted to a single cell line.  The release of cytochrome c in 
a wave that occurs at one, two or multiple points in the cell indicates that the initial 
trigger of the cytochrome c release wave can occur independently at multiple spatially 
distinct points in the cells.  This indicates that the biochemical precursor of cytochrome c 
release is not a homogenous event within the cell, and instead is an accumulation of 
activated factors at spatially localize points in the cell. 
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Figure 42: Spatial patterns of cytochrome c release.  (A) Release initiating from one 
point in the cell.  Release begins at the top of the cell and progresses down along the 
cell.  (B) Distance correlation plot of the cell in A shows a linear relation.  (C) 
Release initiating at two points in the cell.  Release begins at the bottom of the cell, 
and also at the top of the cell.  (D) Quantification of the release indicates two distinct 
linear relations consistent with two points of release.  (E) Release that does not show 
a spatial pattern.  (F) Quantification of the release in E. 
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Figure 42 
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Table 3: Different patterns of cytochrome c release in response to different stimuli 
 
Dynamics of Loss of ΔΨm and Cytochrome c Release 
We next investigated the spatial and temporal relationships between events 
thought to be coincident with, or mechanistically linked to, cytochrome c release 
(Munoz-Pinedo et al., 2006).  We first observed the dynamics of cytochrome c release 
relative to the loss of mitochondrial inner membrane potential (ΔΨm) as monitored by 
tetramethylrhodamine ethyl ester (TMRE).  TMRE preferentially accumulates in actively 
respiring mitochondria (Ehrenberg et al., 1988), and during apoptosis TMRE is lost from 
the mitochondria at the same time as cytochrome c (Munoz-Pinedo et al., 2006).  
Although TMRE loss is temporally proximal to the release of cytochrome c, it has been 
observed that the pan-caspase inhibitor zVAD-fmk can delay the loss of TMRE relative 
to cytochrome c GFP (Goldstein et al., 2000). 
 HeLa cells were transfected with cytochrome c-GFP and loaded with 
TMRE.  When these cells were treated with TRAIL (1 μg/mL), we observed that the 
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release of cytochrome c-GFP from the mitochondria preceded the loss of ΔΨm (Figure 
43A).  Furthermore, the loss of ΔΨm followed the same spatial patterns as cytochrome c 
release within the cell, though lagging in time (Figure 43A).  This time delay was 
quantified monitoring cytochrome c release and TMRE loss from a single ROI (Figure 
43B). 
To demonstrate the lag between TMRE loss and cytochrome c release for the cell 
shown in Figure 43A, we plotted the correlation between distance from the first ROI to 
release and the time of release for both cytochrome c release and of TMRE loss (Figure 
43C).  This shows that TMRE has a similar distance-time release plot that differs in that 
it is shifted in the time axis.  Furthermore, a correlation between the time of TMRE loss 
and cytochrome c release in this cell shows that TMRE loss occurs after cytochrome c 
release (Figure 43D).  Finally, in 5 cells with a total of 150 ROI, we found that 146 of 
150 ROI studied released cytochrome c-GFP before ΔΨm loss (Figure 43E).  The average 
time between cytochrome c release and ΔΨm loss in TRAIL treated cells was 90 ± 42 
seconds (Figure 43E), demonstrating that loss of ΔΨm is not necessary for and does not 
occur before cytochrome c release.  Note that 2.7% (4 of 150) of ROI show that TMRE 
loss occurs before cytochrome c release. This may result from an error in determining the 
time at which fluorescence irreversibly decreases in an ROI.  These results demonstrate 
that cytochrome c is released from mitochondria before membrane potential is lost.  
Unlike previous reports, these experiments were conducted in the absence of biochemical 
inhibitors (Goldstein et al., 2000; Munoz-Pinedo et al., 2006).   
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Figure 43: Mitochondrial release and loss of TMRE.  HeLa cells treated with 2μM 
of STS.  (A) Release of cytochrome c proceeds from left to right around the nucleus 
(top panel).  TMRE loss occurs in approximately the same pattern but lagging in 
time (lower panel). (B) The average intensity in a single ROI of cytochrome c-GFP 
(black +) and TMRE (gray ×) versus time.  (C) Correlation plot of distance of 
cytochrome c-GFP release and TMRE loss as a function of time.  (D) Correlation of 
the time of cytochrome c-GFP release and the loss of potential for all regions. Gray 
line indicates simultaneity.  (E) Histogram of the time difference between 
cytochrome c release and TMRE loss for 150 ROI in 5 HeLa cells treated with 
TRAIL (positive values indicate that cytochrome c is released before TMRE loss). 
The average release difference is 90 ± 42 seconds.  
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Dynamics of Cytochrome c and Smac Release 
 
Next we observed the release of Smac, a mitochondrial protein that is released to 
the cytosol where it promotes apoptosis by inducing the degradation of the inhibitor of 
apoptosis proteins (IAPs) (Du et al., 2000; Verhagen et al., 2000).  Previous work 
indicated that fluorescently-tagged Smac is simultaneously released with cytochrome c-
GFP (Munoz-Pinedo et al., 2006).  By simultaneously monitoring Smac-mCherry and 
cytochrome c-GFP at rates faster than previously published, we found that the release of 
Smac-mCherry followed the same spatial pattern as cytochrome c-GFP, but lagging in 
time (Figure 44).  
We quantified the Smac delay using a similar analysis used to quantify the delay 
in TMRE loss (Figure 45).  First we found that cytochrome c release preceded Smac 
release in a single ROI (Figure 45A).  Next we plotted the distance of cytochrome c and 
Smac release as a function of time for the cell in Figure 44, and found that Smac release 
generally followed cytochrome c release (Figure 45B).  This was also demonstrated by a 
correlation plot of the time of cytochrome c and Smac release (Figure 45C).  Finally, by 
monitoring 312 ROI in 6 different cells, we found that Smac release followed cytochrome 
c-GFP release in 301 of 312 ROI with an average delay of 42 ± 29 seconds (Figure 45D).  
A few ROI (11 of 312; 3.5%) show that Smac is released before cytochrome c, which 
may result from an error of determining the time at which fluorescence irreversibly 
decreases in an ROI. 
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Figure 44: Widefield time lapse images of cytochrome c-GFP release and Smac-
mCherry release in the same cell.  HeLa cells were treated with 2 μM of STS.  
Cytochrome c release starts at the top of the cells and propagates to the bottom of 
the cell.  Smac release lags in time behind cytochrome c release, but follows a similar 
pattern. 
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Figure 45: Quantification of cytochrome c-GFP release and Smac-mCherry release 
in the same cell.  HeLa cells were treated with 2 μM of STS.  (A) The average 
intensity in a single ROI of cytochrome c-GFP (black +) and Smac-mCherry (gray 
×) versus time. (B) Plot of cytochrome c-GFP release and Smac-mCherry release as 
a function of time.  (C) Correlation of the time of cytochrome c-GFP release and the 
time of Smac-mCherry release for all regions. Dotted line indicates simultaneity.  
(D) Histogram of the time difference between cytochrome c release and Smac 
release for 312 ROI in 6 HeLa cells treated with TRAIL(positive values indicate that 
cytochrome c is released before Smac).  The average release difference is 42 ± 28 
seconds. 
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We observe a delay between loss of ΔΨm and Smac release, relative to cytochrome 
c release, and all three events occur in a similar spatial pattern.  Although the release is 
distinct, the spatial and temporal similarity suggests that there is one underlying 
mechanism governing cytochrome c and Smac release and ΔΨm loss from individual 
mitochondria.  The delay observed between the Smac and cytochrome c waves could be a 
result of pores that preferentially release cytochrome c and then Smac.  However, a delay 
could also be caused if Smac is oligomerized with itself or another protein (Du et al., 
2000).  The time between cytochrome c-GFP loss and loss of membrane potential could 
result from a delay associated with the breakdown of the electron transport chain, 
although there is evidence that loss of potential requires caspase activation (Goldstein et 
al., 2000; Goldstein et al., 2005).  
 
Mitochondrial Fission 
We next investigated the temporal relationship between cytochrome c release and 
mitochondrial fission using the mitochondrial marker mito-mCherry (Figure 46).  
Mitochondrial fission proteins have been implicated in cytochrome c release during 
apoptosis (Suen et al., 2008; Frank et al., 2001; Karbowski et al., 2002).  Furthermore, 
mitochondrial fragmentation is reported to occur simultaneously with, or within minutes 
of cytochrome c release (Karbowski et al., 2002).   
122 
 
To resolve the timing of these events, we first monitored individual mitochondria 
located primarily at the periphery of cells where there is lower spatial density of 
mitochondria.  In HeLa cells treated with TRAIL (1μg/mL), we observed that 
cytochrome c-GFP was released prior to mitochondrial fission (24 mitochondria in 9 
cells).  A representative image of cytochrome c release and mitochondrial fission from a 
single mitochondria is shown in Figure 47.  
Alterations in the mitochondrial morphology were observed in the time between 
cytochrome c release and prior to mitochondrial fission.  The morphological alterations 
were characterized by the formation of multiple fluorescent aggregates with thinner 
intermediate connections (Figure 48A).  These fluorescent aggregates and intermediate 
connections were quantified with a line scan of mitochondria (Figure 48B).  The size, 
distribution, and duration of these aggregates varied between mitochondria (data not 
shown).  In total we observed similar intermediate morphologies for 15 of 23 
mitochondria observed. 
The observation of alterations of mitochondrial morphology indicates that 
structural changes may precede complete mitochondria fission.  These changes could be 
due to the restriction of mitochondria by proteins such as Fis1, and Drp1 (Karbowski et 
al., 2002) the formation of pores at the restriction sites (Kuwana et al., 2002) or the 
swelling of the inner membrane space (Sun et al., 2007).   
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Figure 46: Mitochondrial morphology before, during, and after cytochrome c-GFP 
release. Mito-mCherry showing mitochondrial morphology in a HeLa cell treated 
with TRAIL. Cytochrome c release began at t =0. Scale bar = 5μm 
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Figure 47: Images of a single mitochondria undergoing cytochrome c release and 
mitochondrial fission.  HeLa cells were transfected with (A) mito-mCherry and (B) 
cytochrome c-GFP  and treated with 2μM of TRAIL.  In white boxes are the frames 
where cytochrome c release is occurring.  Images are taken every 5 seconds. 
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Figure 48: Mitochondrial fission and release of cytochrome c from single 
mitochondria. HeLa cells transfected with cytochrome c-GFP and mito-mCherry, 
and treated with TRAIL. (A) Images of cytochrome c release and mitochondrial 
fission. Cytochrome c release begins at time t = 0. Arrows indicate sites of fission; 
arrowheads indicate sites of morphological changes. (B) Line scans of mitochondria 
from A with mito-mCherry in black and cytochrome c-GFP in gray. Arrows 
indicate corresponding positions of arrows on image. 
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Release of Cytochrome c from individual mitochondria  
We imaged cytochrome c release from individual mitochondria to determine 
whether release occurred in a single step, as a two step process (Ott et al., 2002), or 
moved like a wave across each mitochondria.  It has been shown that cytochrome c is 
localized to intra-cristae regions of the mitochondria with limited access to the 
intermembrane space (Scorrano et al., 2002). The release of cytochrome c from 
individual mitochondria is difficult to monitor because of the variable onset of apoptosis 
within single cells, and the rapid release of cytochrome c from individual mitochondria.   
Furthermore, the density of mitochondria makes it very difficult to discern individual 
mitochondria in wide field or confocal microscopy.  To overcome the timing problem we 
imaged several single cells once every minute, and once cytochrome c was released in a 
single cell, we monitored adjacent cells once every ten seconds.  These cells were then 
imaged every 10 seconds, until cytochrome c release was detected in single mitochondria 
and then we acquired images once every 400 ms.   
For improved spatial resolution of individual mitochondria we imaged with total 
internal reflection microscopy (Axelrod, 1989),  which illuminates only the very bottom 
of the cell within 200nm of the coverslip.  This allows imaging of a subset of 
mitochondria with limited out of focus background fluorescence. Under these conditions 
we could monitor the cytochrome c-GFP throughout the length of the mitochondria 
(Figure 49A). Decrease in cytochrome c-GFP fluorescence appeared to initiate at the 
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same time through the entire mitochondria.  A quantification of the fluorescence 
demonstrated that neither the time when cytochrome c release initiated nor the time 
course of release, were functions of the position along the mitochondria (Figure 49B).   
 
Figure 49: (A) Release of cytochrome c-GFP from individual mitochondria as 
revealed by TIR microscopy. Cytochrome c release begins at time t = 0. (B) 
Quantification of cytochrome c release from different regions of the single 
mitochondria in A. Release appears to initiate at the same time throughout the 
mitochondria. Scale bars represent 5 μm. 
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Inhibition of cytochrome c Release Wave 
The spatial waves of release illustrate that cytochrome c is not simultaneously 
released from all mitochondria in a single cell.  Potential mechanisms to explain the 
spatial coordination of cytochrome c release include local activation of a precursor to 
release and a feed-forward loop that amplifies the initial loss of mitochondrial proteins.  
There is evidence suggesting a link between cytochrome c release, inositol 1,4,5 
triphosphate receptor (IP3R), and ER calcium stores (Boehning et al., 2005; Boehning et 
al., 2003).  This potential role for calcium is consistent with the ability of the Bcl-2 
family to modulate cellular calcium levels (Foyouzi-Youssefi et al., 2000; Palmer et al., 
2004; Scorrano et al., 2003), as well as the observation of calcium waves in apoptotic 
cells (Pacher and Hajnoczky, 2001; Szabadkai et al., 2004).   
We tested the effects of reducing the cytosolic calcium with BAPTA-AM and 
depleting ER calcium with thapsigargin (Palmer et al., 2004) on the spatial and temporal 
characteristics of cytochrome c release.  HeLa cells expressing cytochrome c-GFP were 
treated with TRAIL (1 μg/mL) to induce apoptosis in the presence of extracellular EGTA 
(1.2mM). Once one cell in the field released cytochrome c, BAPTA-AM (1mM) was 
added to the bath.  Calcium levels were stably reduced within 5 minutes of BAPTA-AM 
addition to media (data not shown).  The time for 95% of the ROIs in a cell to release 
cytochrome c-GFP increased slightly from 112 ± 31 seconds for cells treated with TRAIL 
and EGTA, to 153 ± 49 seconds (p=0.025) for cells treated with BAPTA-AM (Figure 
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50A). There was a negligible change in the fraction of cells with a directional release 
(from 0.50 to 0.57, Figure 50B).  The effects of thapsigargin (5μM), were larger in 
magnitude and significance.  The time for a cell to release cytochrome c increased over 
four fold (112 ± 31 sec to 511 ± 245 sec, p=2.2*10
-6
, Figure 50A) in cells that were 
treated with thapsigargin.  Additionally, thapsigargin reduced the fraction of cells 
showing directional release patterns from 0.5 to 0.053) (Fig. 48B). Thus thapsigargin 
both disrupted the spatial wave of cytochrome c release and increased the duration of 
release by more than 6 minutes. 
 
Summary 
In this chapter, we described the spatial coordination of cytochrome c release, 
Smac release, and loss of ΔΨm. We observed that cytochrome c release occurs in a wave 
that can initiate from one point in the cell, two points in the cell, or randomly through the 
cell (Figure 42).  The spatial wave of release could be observed with staurosporine, 
TRAIL and etoposide indicating that this is a phenomena that occurs in different modes 
of apoptosis.  Smac release and loss of ΔΨm lagged in time behind cytochrome c release.   
However, in single cells, Smac release, and loss of ΔΨm exhibited the same spatial 
pattern as cytochrome c release (Figures 43, 45).  Finally, we observed that mitochondria 
underwent fission after cytochrome c release (Figure 48). The wave of cytochrome c 
release was inhibited by treatment with thapsigargin (Figure 50). 
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Figure 50: Thapsigargin, but not BAPTA, disrupts the wave of cytochrome c 
release. HeLa cells in 1.2 mM EGTA undergoing TRAIL-mediated apoptosis were 
treated with 1 mM BAPTA-AM (BAPTA) or 5 μM thapsigargin. (A) Duration of 
cytochrome c release (95% of all ROIs released). Thapsigargin increased the 
duration of release (p = 2.2 × 10
−6
), whereas BAPTA did not (p = 0.025). 
Thapsigargin, but not BAPTA, disrupts the wave of cytochrome c release. HeLa 
cells in 1.2 mM EGTA undergoing TRAIL-mediated apoptosis were treated with 1 
mM BAPTA-AM (BAPTA) or 5 μM thapsigargin.  (B) Bar graph showing the 
fraction of cells with directional release. Numbers indicate (directionally releasing 
cells)/(total cells). 
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Figure 50 
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Figure 51:  
Chapter Five: Conclusions and Future Directions 
 
In this thesis we described the development of two new reporters for monitoring 
caspase activation in single cells (Chapter Two).  This reporter was expressed in a 
population of cells where we observed a similarity in the time of caspase activation of 
related cells relative to the overall population (Chapter Three).  This similarity in 
apoptosis timing was used to monitor mitochondrial apoptotic events in single cells with 
high temporal resolution where we observed the spatial pattern of cytochrome c release 
(Chapter Four).  Below we discuss the implications of this work, and potential future 
directions. 
 
Caspase Reporter 
The designed reporters (erDEVD and pmDEVD) relocalize from one organelle to 
another after caspase activation.  The pmDEVD reporter consists of a single fluorophore 
which is relocalized from the plasma membrane to the cytosol after the activation of the 
caspases, and the erDEVD reporter relocalizes from the ER to the nucleus after caspase 
activation.  On the basis of signal strength and kinetic properties the pmDEVD reporter is 
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comparable to or better than other genetically encoded caspase reporters (FRET, 
pCaspase-3, and erDEVD).  Importantly, the reporter uses only a single fluorophore 
which enables simultaneous use of the pmDEVD reporter along with probes for other 
processes.  Here, we were able to simultaneously monitor other events such as the cell 
cycle and cytochrome c release.  Finally we determined that the expression of the 
pmDEVD reporter does not have an effect on the kinetics of downstream steps of 
apoptosis such as TUNEL staining.   
 
The relocalization reporters can be modified to other proteases such as granzymes 
or initiator caspases by modifying the cleavage domain (Thornberry et al., 1997).  This is 
potentially difficult owing to overlapping substrate specificities and low levels proteolytic 
activity in weaker proteases (such as the initiator caspases).  To improve the reporter 
signal for detection of weaker proteases future modifications might include co-
translational targeting to the plasma membrane, and the addition of a nuclear localization 
signal.  This would aggregate the cleaved fluorophores in the nucleus which would be 
more easily detectable than if the reporter is localized to just the cytoplasm.  Furthermore, 
to aid in the detection of weaker caspases, it may be useful to fuse protein-protein 
interaction domains such as CARD (for the detection of caspase-9) or DED domains (for 
the detection of caspase-8) to these reporters to help localize these weaker caspases to the 
reporter. 
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Sister Cell Apoptosis 
We observe that sister cells undergo activation of caspase-3/7 at similar times 
relative to the population.  This similarity could not be correlated to the position of cells 
in the cell cycle, nor to the distance between cells.  By investigating the similarity of 
apoptosis susceptibility over subsequent generations, we observe a divergence in the 
times of apoptosis as cells are more unrelated.  A divergence in apoptosis susceptibility is 
also observed within single generations and is limited by blocking protein synthesis after 
division.  These results suggest that the signal transduction in response to apoptotic 
stimuli reflects the internal state of the cell and therefore is deterministic.  
 
Overview of variability 
A precise apoptotic response might be expected given its importance in executing 
developmental programs or ensuring destruction of aberrant cells.  However, the time 
when a cell irreversibly commits to apoptosis can vary from 1 hour to over 20 hours 
depending on the type and strength of the apoptotic stimulus (Goldstein et al., 2000).  
Variability of cell fate decisions in clonally identical populations is also observed in 
phage lambda infection (Arkin et al., 1998), bacterial chemotaxis (Spudich and Koshland, 
Jr., 1976), cell differentiation (Abkowitz et al., 1996; Enver et al., 1998),  and HIV-1 Tat 
transactivation (Weinberger et al., 2005).  While phenotypic variability can be beneficial 
in certain scenarios such as in stress responses or environmental fluctuations (Kussell and 
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Leibler, 2005) it also imposes limits on the precise control of cellular fate.  In the context 
of apoptosis, variability can be resolved into two components: a stochasticity in how 
biochemical signals are transduced after drug treatment, or a population-level 
heterogeneity of cellular factors (Kaern et al., 2005).  It is difficult to experimentally 
resolve contributions of the different components owing to an inability to precisely 
replicate the biological conditions of a single cell.   
 
Entry into apoptosis is similar for cells in proximity 
When studying the times of apoptosis in a population, we noticed that the times 
for neighboring cells to enter apoptosis were highly correlated relative to more distant 
cells (Figure 14). One potential explanation for such a correlation would be secreted 
factors, which have been demonstrated to play a significant role in apoptosis.  However, 
three independent tests demonstrated that there was no correlation between when 
caspases were activated and the physical distances between unrelated cells (Figures 23-
26).  Thus, the secreted factors may either be acting only on the secreting cell itself or on 
the culture as a whole, but not affecting the local microenvironment.  Therefore while 
secreted factors play a role in the apoptosis decision, they may not be the underlying 
source of cell-cell variability. 
Depending on the method of inducing apoptosis, previous work reported a 
correlation between apoptosis and the cell cycle (Stacey et al., 2000), or a lack of 
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correlation (Hueber et al., 1998; Cohen et al., 2008).  Since recently divided cells both 
tend to be near each other and tend to be synchronized in the cell cycle, this might also 
account for the “local synchronization”.   This was tested with two different assays: 
Apoptosis was induced in a cell cycle synchronized population (double thymidine block) 
(Figure 16) or apoptosis was induced in an asynchronous population where the cell cycle 
phase was determined using a live cell reporter (Figure 20).  In both assays there was no 
detectable correlation between cell cycle and apoptosis.  .  
  
Entry into apoptosis is similar for related cells 
When neighboring cells were categorized into sister cells, cousins or unrelated 
cells, sister cells showed the greatest similarity for the time of entering apoptosis (Figure 
26).  Apoptosis times of sister cells are most similar right after division, and this 
similarity decreases over time (Figure 34).  When weaker apoptotic insults were used we 
found that not only was the timing of apoptosis correlated for sister cells, but also the 
probably of apoptosing.  Thus, fates were linked in sister cells (Figure 29)  Although 
phenotypic similarities between sister cells have been shown with respect to the duration 
of the cell cycle (Dover and Potten, 1988; Nasmyth et al., 1979), and in some cases cell 
migration (Albrecht-Buehler, 1977) to our knowledge, this has not been shown with 
respect to apoptosis nor for any cellular phenotype in response to an exogenous trigger.   
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Determinism in Apoptosis Signal Transduction 
The similarity of apoptosis times and the apoptotic fate of sister cells suggest that 
the time of apoptosis, and the fate of a single cell in response to an apoptosis stimulus is 
predictable.  This predictability of apoptotic signal transduction suggests that cells which 
undergo apoptosis at a later time relative to the population may have molecular 
compositions that make the cell less susceptible to apoptosis, and do not result from 
stochastic events in apoptosis signal transduction.   
While the difference in apoptosis time between sister cells is much smaller than 
expected if the entry to apoptosis was completely stochastic, the apoptosis times of sister 
cells was not identical (Figure 28).  One explanation is that the biochemical signal 
transduction in response to apoptotic stimuli may have some stochastic steps.  
Alternatively, the dilution of factors during division may not be symmetric, or the 
molecular composition of daughter cells may diverge after division.  The latter 
explanation is consistent results showing that as cells spend more time apart, their 
difference in caspase activation increases (Figure 34). 
 
Divergence of Apoptotic Susceptibility  
Sister and cousin cells underwent apoptosis at similar times but as cells became 
more distantly related, the difference in their times of apoptosis increased (Figure 32, 34).  
This divergence of apoptotic fate was observed to occur over a few generations, 
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suggesting that the molecular composition of the cell which predisposes cells to apoptosis 
is transient.  A similar influence of lineage on phenotypic behavior is seen in the 
switching times of S. cerevisiae that were engineered to switch between galactose 
metabolizing and non-metabolizing states (Kaufmann et al., 2007).   
Our results are reminiscent of prior results on the variability of gene expression in 
a lineage of mammalian cells (Sigal et al., 2006b).  Sigal et al. calculated the kinetics and 
genealogical time over when the gene expression levels in a cell lineage reach the 
different expression levels found in the population.  Our results build upon the 
demonstration of divergence in gene expression, to show a divergence of phenotype 
within a lineage.  Strikingly, our half-time of divergence of the apoptosis response is on a 
similar scale as divergence in the gene expression study, thus suggesting that the 
divergence of gene expression levels in mammalian cells has a phenotypic consequence 
(Newman and Weissman, 2006). 
 
Divergence from New Protein Synthesis 
The similarity in apoptosis time between sister cells is observed for three distinct 
apoptosis inducing drugs (STS, TNFα, and ETO) and in different cell lines and in non-
immortalized MEFs.  This indicates that the mechanism generating diversity and 
persistence of the apoptotic state could be a few proteins common to the different 
apoptosis drugs, or could be a global mechanism affecting all proteins of which variation 
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in apoptosis signaling is only one consequence.  The intragenerational variation in the 
apoptosis susceptibility could result from a gradual change in the cellular components 
which could reflect increasing differences in gene expression.  Notably, Sigal et al. 
reported that variation in gene expression was found for distinct classes of proteins (Sigal 
et al., 2006b).   
The divergence of apoptosis times of sister cells was inhibited by blocking protein 
synthesis after division, suggesting that variation in apoptosis is in part a result of a 
variation in protein synthesis just after division.  Other molecular changes may contribute 
including the degradation of proteins, the post-translational modifications of proteins, and 
the localization of proteins.  We propose that if the molecular composition of the cell, and 
the underlying biochemical network used to process apoptotic triggers is similar between 
sister cells at the time of treatment, the apoptosis times will be similar.  However as the 
molecular composition of cells start to drift apart, so does the apoptotic response.  Thus, 
while the biochemical reactions triggered by an apoptotic signal may be deterministic, the 
reactions that determine the molecular composition of the cell prior to the addition of an 
apoptosis drug may not be. 
An understanding of the mechanisms of apoptosis will be aided by the 
development of techniques to monitor the expression and activity of different apoptotic 
proteins in single cells.  Such reporters can be used along with the developed pmDEVD 
reporter, which uses only a single fluorophore, to correlate the times of reporter 
activation to time of caspase activation.  This will help elucidate both the timing of events 
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and the determination of whether the variability between cells is the result of a specific 
apoptotic stage or of small variations in multiple stages.   
Broadly, these results highlight the benefits of single cell assays in addition to 
monitoring population phenotypes.  In a population, there is a substantial distribution in 
the onset of apoptosis.  This is not just a stochastic transduction of an apoptotic signal, 
but a difference resulting from population heterogeneity.  The determinism of signal 
transduction in single cells should enable the observation of processes that are too rapid 
to be continuously imaged such as cytochrome c or Smac release (Chapter Four).  This 
can be potentially done by waiting for a cell to undergo apoptosis at low imaging 
frequency, then imaging its sister cell, or related cells at a higher frequency.  The 
symmetry of division reproduces underlying biochemical networks that cells use to 
respond to external triggers.  Exploiting this symmetry by comparing responses in sister 
cells enables an understanding of the reproducibility of the response of these signaling 
networks, and how biochemical signals are transduced.  It remains to be seen whether this 
similarity extends to other phenotypes, and whether it extends to phenotypes in vivo. 
 
Cytochrome c Release 
Rapid imaging during apoptosis revealed a spatial coordination of cytochrome c 
release, Smac release, and loss of ΔΨm. Three spatial patterns of cytochrome c release 
were observed: waves initiating at one or two points in the cell, and an apparent random 
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release. The release of Smac and loss of ΔΨm exhibited a spatial pattern similar to that of 
cytochrome c release. Only one temporal pattern was observed: first, the mitochondria 
lost cytochrome c and then they lost Smac, which was followed by the loss of 
mitochondrial energetics, as assayed by the ΔΨm. The mitochondria underwent fission 
after cytochrome c release. The wave of cytochrome c release was inhibited by treatment 
with thapsigargin. 
 
Waves of cytochrome c release 
The cell-wide release of cytochrome c-GFP was previously observed to occur in 
an all-or-none manner (Goldstein et al., 2000) and, more recently, in a wave propagating 
across single or fused cells (Lartigue et al., 2008). The existence of a wave suggests that 
the upstream trigger of cytochrome c release is spatially localized. Though the identity of 
the trigger is unknown, possible triggers include the members of the Bcl-2 family (Youle 
and Strasser, 2008) and the initiator caspases. Here, we observed waves initiating not 
only at a single point in a cell, but also at two spatially distinct points in a cell (Figure 
42). This indicates that although the trigger initiating the wave of cytochrome c release is 
spatially localized, it can occur in multiple locations independently within a single cell. 
Therefore, although there may be multiple points for the initiating pro-apoptotic trigger 
within the cell, cytochrome c-GFP release is initiated only when the concentration or 
activity of the precursor crosses a threshold. 
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Other mitochondrial events 
The similar spatial pattern observed within each cell between the release of 
cytochrome c-GFP and Smac-mCherry and the subsequent loss of ΔΨm suggests that 
although these events are not coincident, they are part of the same process. The temporal 
lag between the release of cytochrome c-GFP and Smac-mCherry could indicate different 
submitochondrial localizations of the proteins, different binding interactions that delay 
release of Smac-mCherry, or a pore that is selective for cytochrome c-GFP. 
The temporal lag that was observed between the release of cytochrome c-GFP and 
the loss of TMRE shows that ΔΨm and thus the integrity of the inner membrane 
permeability and mitochondrial energetics are maintained during cytochrome c release. 
Thus, loss of mitochondria energetics is unlikely to be a causal trigger for the loss of the 
proteins cytochrome c and Smac. This is consistent with a model in which apoptosis is 
initiated in the cytoplasm, permeabilizing the outer membrane, followed by inner 
membrane permeabilization and then loss of potential (Basanez et al., 1999). However, it 
is important to keep in mind that our experiments were done with fusion proteins, which 
may have different localizations than the endogenous proteins, resulting in different 
release dynamics. 
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Mitochondrial morphological changes 
It has been proposed that the release of cytochrome c may be a consequence of 
fission of the mitochondria and the subsequent release of mitochondrial contents 
(Martinou and Youle, 2006). Here, we define mitochondrial fission as the point at which 
a break occurs in the mitochondria as observed by microscopy. The observation that 
cytochrome c-GFP release precedes mitochondrial fission (Figure 47) indicates that 
fission is not necessary for the release of cytochrome c from individual mitochondria. It 
is unlikely that there are significant tears in the mitochondrial membrane that we are not 
detecting due to limited optical resolution, since the mitochondria still maintain their 
membrane potential. However, it is possible that the tears are restricted to only the outer 
membrane. Alternatively, there may be local fissions, but the two halves of the 
mitochondria do not move apart until after the release of cytochrome c and Smac. This 
observation is consistent with evidence that multiple components of the mitochondrial 
fission machinery, such as Drp1, are involved in promoting the release of cytochrome c. 
It is also possible that these proteins are multifunctional and use different mechanisms in 
their roles to reshape mitochondria and to promote the release of proteins from 
mitochondria (Cassidy-Stone et al., 2008). 
When we imaged single mitochondria expressing mito-mCherry, we observed a 
distinct mitochondrial morphology characterized by multiple fluorescent aggregates with 
thinner intermediate connections. This could result from the recruitment of proteins such 
as Bax, Drp1, or Fis1, which cause restrictions at localized mitochondrial sites 
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(Karbowski et al., 2002), or from alterations of internal mitochondria structures (Sun et 
al., 2007). This recruitment or alteration could be a precursor to mitochondrial fission. 
 
Cytochrome c release from a single mitochondria 
To gain insight into the release of cytochrome c, we imaged the release from 
individual mitochondria with subsecond resolution. This revealed that cytochrome c 
release from individual mitochondria occurs in a single step. This imaging technique will 
be beneficial for investigating events associated with cytochrome c release that are too 
fast to image by laser scanning confocal microscopy, and with a greater z-spatial 
resolution than that provided by wide-field or confocal microscopy. 
 
Wave mechanism 
One possible mechanism for the wave of cytochrome c release is a factor that 
diffuses across the cell, triggering the mitochondria to release cytochrome c. 
Alternatively, a wave could result from an initial release of cytochrome c, followed by a 
feed-forward loop that amplifies the initial release. A role for ER calcium in the feed-
forward mechanism is supported by our experiments in cells treated with thapsigargin, 
which showed a prolonged duration and lack of spatial organization of cytochrome c 
release. This is consistent with previous work showing a link between cytochrome c and 
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calcium release from the ER, which in turn triggers cytochrome c release from the 
remaining mitochondria (Boehning et al., 2003; Boehning et al., 2005). However, loading 
the cytosol with 1 mM of BAPTA did not prolong or disrupt the spatial organization of 
the wave. This suggests that calcium signaling does not occur through the cytoplasm, and 
instead occurs through close contacts between the ER and the mitochondria (Rizzuto et 
al., 1998). Alternately, thapsigargin could have an off-target effect, perhaps by altering 
mitochondrial calcium levels, which has been observed with higher concentrations of 
thapsigargin (Vercesi et al., 1993). Ultimately, a biochemical dissection of the 
mechanisms of the wave will be required. 
 
Future Directions 
Cytochrome c Release 
We observed that cytochrome c was released in a wave in response to STS, 
TRAIL and ETO, which trigger apoptosis through stress, death receptors and DNA 
damage pathways respectively.  To gain insight into the origin points of the release wave, 
we could also use other methods to induce apoptosis that stimulate direct components of 
apoptosis pathways.  One possibility would be to use Bcl-2 mimetics or inhibitors to 
determine whether these affect the wave or the number of starting points of the wave.  
For example, we could use the Bcl-2 inhibitor ABT-737 which is proposed to inhibit the 
anti-apoptotic activity of Bcl-2, Bcl-XL and Bcl-W and induce apoptosis (Oltersdorf et 
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al., 2005; Cragg et al., 2009), or we could use obatoclax which is proposed to inhibit the 
interaction between Mcl-1 and Bak (Nguyen et al., 2007), or more generally, we could 
express select BH3 peptides which induce release of mitochondrial proteins by directly 
acting on Bax or Bak (Letai et al., 2002; Walensky et al., 2006).  If there is no spatial 
localization of these molecules or peptides in the cell, then if the spatial pattern of release 
in response to STS or TRAIL is caused by a gradient of Bax or Bak activation in the cell, 
the spatial pattern may not be present in response to ABT-737, obatoclax, or the BH3 
peptides.  
We were able to demonstrate that the application of thapsigargin to cells prior to 
inducing apoptosis was able to inhibit the wave of release, and slow down the overall 
release in the cell.  However, thapsigargin is known to have off target effects (Vercesi et 
al., 1993), and without identifying specific molecules, or without inhibiting the wave 
using another inhibitor, it is not possible to rule out this effect.  Some of the potential 
molecules involved in a feed-forward loop include calcium signaling molecules or 
molecules that are closely associated with both the mitochondria and the endoplasmic 
reticulum.  For example, one of the possible interactions that was not investigated in 
Chapter Four is the interaction of cytochrome c with the IP3R (Boehning et al., 2003; 
Boehning et al., 2005).  It has been demonstrated that cytochrome c interacts with amino 
acids 2621-2636 of type I IP3R thereby stimulating calcium release from the ER, which is 
proposed to induce further cytochrome c release (Boehning et al., 2003).  A peptide 
comprising amino acids 2621-2636 of type I IP3R has been shown to bind to cytochrome 
c, and inhibit the interaction between cytochrome c and endogenous IP3R (Boehning et 
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al., 2005).  It would be interesting to determine if this peptide could inhibit the wave of 
cytochrome c release. 
A more general and less directed approach to identify molecules involved in wave 
propagation would involve performing a screen using a library of shRNA to determine 
which shRNAs would inhibit or modify the wave (Hitomi et al., 2008).  This would 
require setting up a fluorescent assay to monitor the wave in a high-throughput way that 
would enable a screen in a reasonable time.  Our approach to image the wave has been to 
wait for one cell to die, then to image rapidly.  This was done with a 60x objective to get 
the maximal resolution to characterize the phenomenon.  However, this level of 
resolution or prediction of apoptosis may not be necessary to observe the wave.  At 10x 
resolution, it is possible to observe cytochrome c at different areas in the cell.  Thus, 
while it may not be possible to resolve the detail of the waves, or all waves in all cells, it 
may still be possible to see fractional release. 
The low-powered objective would enable the imaging of more cells.  In imaging 
many cells, and by imaging at a time when most cells in the population are releasing 
cytochrome c (i.e. the maximum of the Gaussian), it may be possible to reproducibly 
observe a small percentage of cells undergoing spatial patterns of cytochrome c release.  
This would speed up the experimental time and reduce the effort for monitoring a wave 
of release and may enable a shRNA screen. 
While we were able to monitor the release of cytochrome c in single cells, it is not 
clear if this is a process that occurs in vivo, or whether it is an artifact of cultured cells.  
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One way to test this would be to express a cytochrome c-GFP fusion in mice, and image 
cytochrome c GFP release in tissues undergoing apoptosis.  Alternatively we could image 
cytochrome c homologs in other organisms such as C. elegans (ced-4), or D. 
Melanogaster (though it is not clear whether drosophila cytochrome c is released during 
apoptosis).  In all of these instances, it would be interesting to determine whether the 
wave occurs at the same speed, and whether there is randomly occurring release. 
 
Sister Cell Apoptosis 
While we find that sister cells undergo apoptosis at similar times, these times are 
not exactly the same.  Our data shows that while blocking protein synthesis can reduce 
the dissimilarity, it does not completely eliminate the difference.  Another source of 
dissimilarity is cell-cell variation caused by variation in protein degradation.  Thus we 
could inhibit protein degradation using mg132 at various times after cell division and 
determine whether this has an effect on the divergence of sister cell apoptosis. 
To isolate molecules responsible for the divergence, we could perform a shRNA 
screen.  Again, this would require fully automating tracking the lineage of cells, the onset 
of apoptosis, and the subsequent analysis.  It would then be possible to monitor which 
shRNA alters the similarity or the divergence of apoptosis times.  It is possible that this 
will not only result in the identification of genes involved in apoptosis but possibly 
molecules involved in gene expression regulation and genomic stability. 
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 Finally, to gain insight into what predisposes some cells to undergo 
apoptosis early relative to the population, we could isolate cells based on when they 
undergo apoptosis.  One possibility is to perform this isolation using flow cytometry 
where we sort cells twice: first keeping cells that are alive, then sorting shortly afterwards 
to select cells that have undergone caspase activation in the time between the sorts.  This 
would select for cells that have undergone apoptosis in this short interval.  By assaying 
the gene expression of these cells it might be possible to identify specific molecules that 
are up or down regulated in early or late dying cells.  This analysis presumes that there 
are subsets of molecules that are responsible, and that not all molecules are changing.  
For example, different cells may have different molecular reasons for their susceptibility, 
which could confound this experimental approach.   
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Chapter Six: Experimental Procedures 
General Methods 
Cell Culture  
HeLa, NIH3T3, MEF, B16F0, and HT1080 cells were maintained at 5% CO2 in 
DMEM (Gibco) containing 10% FBS (Gibco).  Cells were maintained on 10 cm 
polystyrene dishes (Corning), and were passaged approximately every two days.  For 
imaging, cells were plated on Mattek glass bottom dishes.  Two different sized dishes 
were used depending on the nature of the experiment (10mm and 20mm).  Long term 
multiwell imaging experiments were performed in 24 well dishes (BD Bioscience). 
 
Induction of Apoptosis  
Apoptosis was induced with sFasL (BioVision, Mountain View, CA), TRAIL 
(BioVision), staurosporine (Sigma, St. Louis, MO), etoposide (BioVision), TNFα 
(BioVision), cycloheximide (Sigma).  Drugs were mixed with media well prior to the 
addition of media to cells 
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Transfection 
Cells were transiently transfected with Lipofectamine 2000 (Invitrogen), or with 
Fugene (Roche).  Fluorescence expression started to occur as early as 8 hours after 
Transfection. 
Generation of Stable Cell Lines 
Stable cell lines were generated using lentiviral infection.  Briefly cDNA was 
cloned into a pLNCX vector (Clontech).  HEK293T Phoenix cells – which express viral 
coat proteins -  were transfected with the pLNCX modified vector, thus producing viral 
particles.  Supernatant containing viral particles were collected diluted 1:2 in DMEM and 
added to the target cells.  Cells were allowed to grow over several days.  Infection 
efficiency varied from ~ 5% to 20 %.  Cells were selected using flow cytometry 
(Rockefeller FACS Center). 
 
Fluorophores 
We used the fluorophores mCerulean, mCitrine, mCherry for the non-FRET 
constructs.  CyPet and yPet (optimized from CFP and YFP respectively) were used in the 
FRET construct.  mCherry and mCitrine were obtained from Roger Tsien (Shaner et al., 
2004).  CyPet and yPet obtained from Patrick Daugherty (Nguyen and Daugherty, 2005).  
mCerulean was obtained from David Piston (Rizzo et al., 2004).   
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Fluorescence Microscopy 
For widefield microscopy, we used an Olympus IX-81 microscope with Xenon 
lamp illumination source, and an Orca ER CCD camera (Hamamatsu).  This microscope 
had an automated stage to enable the collection of data from multiple fields (Prior 
Scientific).  The images were recorded using exposure times of 100-300ms.  Image 
acquisition was performed using Metamorph software (Molecular Devices, Sunnyvale, 
CA).  .  The microscope was enclosed by a plexiglass chamber made by the Rockefeller 
High Energy Machine Shop.  We used a 60x 1.2NA water immersion objective, a 40x 0.8 
NA air objective and a 10X 0.6 NA air objective. 
Filter settings were organized to enable the detection of multiple fluorophores in 
the same cell.  All filters were purchased from Chroma.  The filters are listed below: 
Table 5: Olympus IX81 Filters 
Fluorophore Excitation Filter Emission Filter Dichroic 
DAPI 360/40 400/LP DAPI 61002 
Polychroic 
mCerulean ET 430/24 ET470/24 CFP/YFP/mCherry 
89006 polychroic 
GFP HQ 470/40 HQ 520/50 495 long pass 
mCitrine ET 500/20 ET 535/30 CFP/YFP/mCherry 
89006 polychroic 
mCherry/TMRE ET 577/25 ET 632/60 CFP/YFP/mCherry 
89006 polychroic 
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Long term imaging (between 24 and 96 hours) was performed in DMEM with 10% FBS, 
and in 5% CO2.  The temperature was maintained at 37
o
C  using a homemade 
temperature box.  Cells were imaged in Matek dishes or in 24-well dishes.  Imaging in 24 
well dishes was done to increase the number of cell conditions per experiment.  Dishes 
(Mattek or 24 well dishes) were wrapped in parafilm or laboratory tape to minimize the 
loss of 5% CO2 Media exchange was performed at least every 24 hours during imaging 
was performed using tubes inserted through the top of the dish.  The 5% CO2 was also 
perfused through the top of the dish.  At least three fields per well was accquired over an 
experiment.  Media exhange occured via tubes inserted through the top of the dishes.  
Untreated cells at 92 hours appeared normal. 
 
Confocal microscopy differs from widefield microscopy in that it eliminates out 
focus light using a pinhole.  Confocal imaging was performed on a Zeiss510 confocal 
microscope using a 60x objective.  (BioImaging Facility, The Rockefeller University).  
Fluorophores were excited using a laser excitation source (Table 5).  Cells were 
maintained at 37
o
C using a Warner Heating Chamber, and were imaged in Cell Imaging 
Media (Hanks BBS (Sigma) 9.8g/L, 10mM Hepes; 5% FBS; pH 7.4).  Image acquisition 
was performed with Zeiss software.  The following fluorophores were imaged with the 
following filters: 
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Table 6: Confocal Microscopy Filters 
Fluorophore Excitation Filter Emission Filter Dichroic 
mCerulean 458 laser 473-498 BP 458/514 dichroic 
GFP  HQ 520/50 488/543 dichroic 
mCitrine 514 laser 550/50 BP 458/514 dichroic 
mCherry/TMRE 543 laser 560 LP 488/543 dichroic 
 
We also used total internal reflection microscopy to image single mitochondria 
releasing cytochrome c at rapid time resolution.  Excitation was with a 488nm (Spectra 
Physics) and 561nm (Melles Griot) laser for GFP and mCherry respectively, a 488/561 
polychroic mirror, a Cairn OptosplitIII image splitter (Cairn Research) with a 580lp 
dichroic to split the channels and emission filter 525/50 for GFP and 632/60 for mCherry, 
and an OrcaER CCD camera. The TIR microscope was controlled with Metamorph 
software . All filters and dichroics are from Chroma.  
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Chapter Two Methods 
Plasmid Design 
This outlines the cloning details to make the constructs.  All primers are listed in 
5‟  3‟ format.  All primers were ordered from Genelink.  The pmDEVD reporter was 
anchored to the plasma membrane by using the N-terminal palmitoylation site from GAP-
43.  This was PCR amplified from pECFPmem (Clontech) using the primers: 
Forward: GCGCGCTAGCAATAGATCTTGTTTAGTGAACATGCT
GTGCTGTATGAGA 
Reverse: GATGAGGACCAAAAGATCTCATCGTCTGAATTGTCT
GGTGATGAAGTTGATGGATCTTCTGGTTCTGAATTCG
CGC 
 
The DEVD site is contained in the reverse primer.  This was inserted into the 
pECFP-C1 vector in the restriction sites NheI and EcoRI.  Fluorescent proteins were 
swapped by digesting with EcoRI and XhoI, and inserting fluorescent proteins PCR 
amplified with the primers: 
Forward: GCGCGAATTCTCATCTACCGGTATGGTGAGCAAGGG
CGAG 
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Reverse: ATGGACGAGCTGTACAAGCTCGAGCATAACTAAGGA
TCCGCGC 
 
This encodes the construct shown in Figure 5: 
Palmitoylation- sselsgdevdgssgsefssstg-Fluorophore 
 
The pmControl construct is a variant of pmDEVD without the DEVD.  This was 
made by PCR amplifying the palmitoylation site with primers that did not contain the 
DEVD site: 
Forward: GCGCGCTAGCAATAGATCTTGTTTAGTGAACATGCT
GTGCTGTATGAGA 
Reverse: GATGAGGACCAAAAGATCTCATCGTCTGAATTGTCT
GGTGGATCTTCTGGTTCTGAATTCGCGC 
 
This resulted in the construct: 
Palmitoylation-sselsggssgstg-Fluorophore 
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pCaspase-3 sensor was initially distributed by Clontech with a GFP, which limits 
the simultaneous observation of other fluorophores.  We first amplified the NES from the 
pCaspase-3 sensor and in the process added a DEVD domain, and an EcoRI site.  This 
was inserted into the NheI and AgeI sites in pECFP-C1.  Next, we amplified mCherry 
and inserted this into the AgeI and XhoI sites.  Next, the NLS from the pCaspase-3 sensor 
was amplified and inserted between the XhoI and BamHI sites.  Finally to create a 
control plasmid, we inserted amplified mCerulean using the control primers, and inserted 
these between the EcoRI and XhoI sites.  The primers used are below: 
 
NES Primers: 
Forward: GCGCGCTAGCAATAGATCTTGTTTAGTGAACATGAA
CCTGGTGGACCTC 
Reverse: GAGCTGGACGAGCAGCAGGAATTCTCATCGTCTGAA
TTGTCTGGTGATGAAGTTGATGGATCTTCTGGTTCTT
CATCTACCGGTGCGC 
 
Fluorescent Protein Primer: 
Forward: GCGCACCGGTATGGTGAGCAAGGGCGAG 
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Reverse: ATGGACGAGCTGTACAAGCTCGAGCATAACTAAGGA
TCCGCGC 
 
NLS Primers: 
Forward: GCGCCTCGAGTCTGATCCAAAAAAGAAGAGA 
Reverse: GGATCCACCGGATCTAGATAAGGATCCGCGC 
 
Control Primer 
Forward: GCGCGAATTCTCATCGTCTGAATTGTCTGGTGGATCT
TCTGGTTCT 
Reverse: ATGGACGAGCTGTACAAGCTCGAGCATAACTAAGGA
TCCGCGC 
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To create the erDEVD reporter, the first transmembrane domain of Sec63 was 
PCR amplified from a cDNA library using the primers: 
Forward: GCGCGCTAGCATGGCCGGGCAGCAGTTC 
Reverse: TGGTATCGTAAGCTTTCTGAA TTCGCGC 
 
This was inserted into the aforementioned pCaspase-3 vector, excising the NES resulting 
in: 
Sec63(1-68)-sselsgdevdgssgstg-Fluorophore-NLS(3) 
 
The erControl construct was created by inserting the Sec63 (aa 1-68) into the 
pCaspase-3 Control reporter using the erDEVD primers, and the restriction sites EcoRI, 
and NheI.  This resulted in the following construct: 
Sec63(1-68)- sselsggssgstg -Fluorophore-NLS(3) 
 
This FRET-DEVD construct was made using the CyPet and yPet vectors which 
have been optimized to produce a large change in FRET.  This was created by PCR 
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amplifying CyPet using the primers below and inserting into the NheI and BamHI 
restriction enzyme sites of pEGFP-C1 
Forward: GCGCGCTAGCATGGTGAGCAAGGGAGAG 
Reverse: ATGGACGAACTGTACAAATCCTCGTCCGAGCTCAGC
GGAGATGAGGTCGATGGATCCCCAAA 
 
Subsequently yPet was amplified using the primers below and placed into the 
BamHI and HindIII sites in the previous vector. 
Forward: TTTGGGGATCCAGCGGAAGCGAATTCTCTTCAACCG
GTATGGTGAGCAAAGGCGAAGAG 
Reverse: AACGAGCTCTATAAGTAAAAGCTTGCGC 
 
The DEVD site is contained in the primers: 
CyPet–sselsgdevdgssgsef-yPet 
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Reporter Quantification 
Analysis of changes in live single cell fluorescence (for initial reporter 
characterization experiments) were quantified in Metamorph.  To quantify changes in the 
pmDEVD reporter, a single region within the cytoplasm was chosen.  Fluorescent 
proteins fused to the palmitoylation domain localize to the Golgi as well as the plasma 
membrane.  Therefore in choosing a cytoplasmic region to quantify the changes in 
fluorescence, the Golgi aggregate fluorescence was avoided.  To quantify fluorescent 
changes in the erDEVD reporter and the pCaspase-3 sensor, we monitored nuclear 
fluorescence.  Finally changes in the FRET-DEVD construct were quantified by 
monitoring the ratio of CFP/YFP in a single cytoplasmic region.  During all 
quantification, a background subtraction of each fluorescent channel was performed.   
 
TUNEL Staining 
TUNEL staining was performed to assay double stranded breaks.  Cells were 
transiently transfected with the pmDEVD reporter, treated with staurosporine (2µM), 
fixed at different time points, and were stained.  TUNEL staining of STS (2µM) treated 
HeLa cells was performed in glass bottom 96 well plates (BDBiosciences).  We analyzed 
untreated cells, thereby determining a fluorescence range for non-apoptotic cells, and we 
also monitored cells that were treated for 8 hours with STS, and determined an apoptotic 
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range.  In each well we determined whether cells were TUNEL positive, and transfected 
with the pmDEVD-mCherry reporter.  In each well this was continued until we counted 
50 transfected cells, and 50 untransfected cells.  The percentage of TUNEL positive cells 
for transfected and untransfected cells was calculated, and averaged over three wells for 
each time point.   
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Chapter Three Methods 
Plasmids 
The G1/S cell cycle reporter consists of the PSLD domain (amino acids 957-1087 
of human DNA Helicase B) fused to mCitrine.  The reporter is in the nucleus in G1 
phase, and translocates to the cytoplasm during the G1/S transition when PSLD is 
phosphorylated by CyclinE-CDK2.  The PSLD domain from Human DNA Helicase B 
was PCRed from a HeLa cDNA library using the primers below.  This was inserted into a 
vector similar to pEGFP-C1 (between XhoI and EcoRI) with mCitrine in the place of 
EGFP. 
Forward: GCGCCTCGAGCTTCTAGCGGCGCACCTCCA 
Reverse: GATAATCAAGAAACTTAGGAATTCGCGC 
 
The triple repeat of the SV40 NLS was PCR amplified from pEYFP-Nuc and 
placed into a vector similar to pEGFP-C1 with mCerulean in the place of EGFP between 
the restriction sites XhoI and EcoRI.  
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Correlation between Inter-Cell distance and Caspase-3/7 activation 
The determination of the position of cells and their times of apoptosis was 
performed in Metamorph and Excel.  The time of caspase-3/7 activation was determined 
by circling a region which was approximately the center of cells and determining when 
fluorescence irreversibly increased above background.  When this did not give a clear 
result (potentially owing to movement of the cell) the time of caspase-3/7 activity was 
visually determined by looking at the time-lapse images.  If the onset of caspase-3/7 
activation was still not clear, the cell was excluded from the analysis.  The center of the 
circled region was recorded as the position of the cell.  The position of cells was the 
position at the time of drug treatment. 
Analysis of the distance between cells and their times of apoptosis was performed 
in MatLab.  The program would get the position and times of apoptosis of all cells in a 
field.  Distance was calculated as the distance between the approximate center of cells, 
and not the edges of cells.  For every cell pairing the distance and the absolute value of 
the difference of caspase-3/7 activation in the cells was calculated.  This data was binned 
based on distance producing plots such as Figure 15.  Error bars indicate the 95% 
confidence interval of the mean so as to visualize the confidence in the average and not 
the distribution. 
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For analysis of inter-cell distance and caspase-3/7 activation for cells that were 
not sister or cousin cells, we performed the same analysis as above, but excluded sister or 
cousin comparisons from the calculation. 
Analysis of plating at different times and correlating distance to difference in 
caspase activation was performed as above.  The times of the actual caspase activation 
difference was normalized to the caspase activation difference for cells whose position 
were randomly reassigned (null hypothesis).  This was a result of variability in the time 
difference for cells that are very far apart at the different plating times.   
 
Cell Cycle Analyses 
Long term imaging was performed on the Olympus IX-81 in widefield 
microscopy.  The analysis of the time of onset of caspase-3/7 activation was performed in 
Metamorph.  The specific time of caspase-3/7 activation, as measured by pmDEVD-
mCherry, was determined as the time when the cytosolic fluorescence irreversibly 
increased above the basal level.  Cell tracking and the analysis of the G1/S transition was 
performed in Imaris (using the Spot Module).  Specifically, the nucleus was tracked using 
Cerulean-NLS.  For a single cell, this resulted in a moving region of interest marking the 
nucleus.  The nuclear fluorescence of the mCitrine-PSLD reporter was quantified in this 
moving region of interest, and the time course data was exported to Excel.  The time of 
the G1/S transition was characterized as the time when the mCitrine-PSLD nuclear 
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fluorescence irreversibly decreased from the basal G1 levels (see Figure 18 for an 
example of the PSLD-mCitrine time course data).  After the addition of the drugs the 
cells were not as dynamic, therefore the nuclear tracking was not required to measure the 
pmDEVD-mCherry reporter. 
Alternatively, cell cycles were synchronized with a double thymidine block (15 hr 
block, 10 hr release, 15 hr block) and released for variable times (Figure 165).  Controls 
to determine DNA content was performed with Hoechst staining (Sigma).  Briefly, cells 
were trypisined, fixed in 4% PFA, and stained with Hoechst (1ug/mL, 20 min), and 
analyzed with BD LSRII flow cytometry analyzer (BS BioScience).  One way ANOVA 
performed in Excel (Fig. S5) 
 
Analysis of Sister Cells and Cell Lineage 
Sister cell pairs were visually determined by monitoring division up to 36 hours 
before drug treatment.  Comparisons of the average time of apoptosis for different cell 
types and different stimuli (Figure 28) was calculated in Excel.  The randomized 
differences were calculated by taking actual times of apoptosis and randomly pairing 
these in Excel. 
Cell death of only part of the population (44% of the population) was induced by 
using a 1µM STS treatment for 45 minutes.  Cells were washed 3 times in fresh DMEM 
after treatment.   Within 36 hours of drug treatment there were some cells that did not 
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divide or undergo apoptosis.  We counted these non-apoptotic, non-dividing cells as 
surviving.  Chi-squared test was performed with p calculated for 2 degrees of freedom 
(Figure 29).   
Analysis of the difference in apoptosis between related cells was performed in 
MatLab (Figure 31). The time of apoptosis of each cell, and a four number identifier of 
the ancestry of each cell was inputted into the program.  Cells that shared the same first 
number were sister cells, cells that shared the same second number, but not the same first 
number were cousin cells, etc.  The program would then calculate the difference in the 
time of caspase-3/7 activation for each pairing of cells, and store it in 4 different arrays 
depending on the relationships between the cell (i.e. if cells were sister cells, data was 
stored in array 1, if cells were cousin cells, data was stored in array 2, etc.).  Histograms 
were plotted in Excel.  Data fit for the memory of the cell was performed using the 
Marquadt-Levenberg Algorithm in Origin or non-linear least squares fit algorithm in 
MatLab using all the data points, and not the average data points.  One way ANOVA of 
clonal cell lines was performed in Excel (Figure 33). 
 
Intergenerational Differences of Caspase Activation 
A subset of sister cells from Figure 34. 4A was re-analyzed to determine both the 
time of apoptosis, and the time since division.  Cells were fit to recovering exponential 
curve as performed in MatLab with calculations for the 95% CI of the fit (Figure 34).  
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Cells were grouped into bins of 500 minutes to demonstrate intra-generational trends 
using Excel (Figure 34).  Error bars of said binned data represent 95% confidence 
interval of the mean. 
 
Protein Synthesis Inhibition 
Protein synthesis was inhibited using Cycloheximide (C7698), and Puromycin 
(Sigma P7255).  Treatment regimes are shown in Figure 35 and 37A. S9A,10A.  Media 
with CHX or puromycin was added through the top of the dish. 
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Chapter Four Methods 
Plasmids 
Plasmids (Cytochrome c-GFP, Mito-mCherry, and Smac-mCherry) were 
transfected using Lipofectamine 2000 (Invitrogen). TMRE (Molecular Probes) was added 
at a concentration of 25 ng/mL for 15 minutes prior to drug addition. Cytochrome-c GFP 
vector was obtained from Douglas Green (Goldstein et al., 2000). Smac-mCherry was 
made by inserting mCherry in the place of CFP in the Smac-CFP vector (from Richard 
Youle). mCherry was obtained from Roger Tsien, and was placed into a vector similar to 
EGFP-C1 (mCherry-C1, made by Florence Koeppel). mCherry was cut using EcoRI and 
XhoI restriction enzyme sites and inserted into the corresponding region of Smac-CFP. 
Mito-mCherry (a fluorescent fusion of the localization tag of cytochrome c oxidase IV) 
was made by inserting mCherry in the place of DsRed in the mito-DsRed vector (Rizzuto 
et al., 1995). This was done by inserting mCherry from mCherry-C1 into mitoDsRed 
using the sites AgeI and XhoI. 
Cells were transfected with cytochrome c-GFP 72 hours before addition of the 
apoptotic drug to allow time for proper cytochrome c-GFP localization.  In experiments 
involving co-expression of Smac-mCherry or mito-mCherry, cells were transfected a 
second time 24 hours before the beginning of imaging.  An area containing at least 2 
transfected cells was imaged at once every 2 minutes until one cell in the field of view 
released cytochrome c.  Then the rate of imaging was increased to once every 10 seconds.   
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Microscopy Controls 
Microscopy controls:  Cells were imaged under experimental conditions in the 
absence of any apoptotic trigger and the release of cytochrome c-GFP from the 
mitochondria was never observed indicating that the release of cytochrome c-GFP was 
not a consequence of the imaging conditions. 
Untreated cells loaded with TMRE were imaged and used to set excitation 
intensity and exposure times that did not induce spontaneous mitochondrial 
depolarizations from free-radical production (Huser et al., 1998).  Cells were imaged 
under experimental conditions in the absence of any apoptotic trigger and the release of 
cytochrome c-GFP from the mitochondria was never observed indicating that the release 
of cytochrome c-GFP was not a consequence of the imaging conditions.   
 
Image and Data Analysis 
Data was analyzed with Metamorph. The FRET ratio was calculated as CFP/YFP 
after background subtraction.  Analysis of the cell cycle reporters were conducted using 
Spot Detection in Imaris (Bitplane, Saint Paul, MN).  Analysis of the differences in times 
of apoptosis relative to both lineage and distance were performed in MatLab and Excel.  
Curve fitting was performed in Origin using the Marquardt-Levenberg Algorithm or 
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MatLab.  Flow cytometry was performed using the BD FACS Aria, and BDLSRII (BD 
Biosciences, Flow Cytometry Facility at The Rockefeller University).  
Image analysis was performed with Metamorph software (Universal Imaging).  
Circular regions of interest (ROIs) with an area of 3μm were selected on the cytochrome 
c-GFP image.  Many ROIs were selected such that a majority of the mitochondria were 
included within at least one ROI.  The ROIs were then transferred to the other channel.  
The average intensity of each ROI over time was calculated.  The time of release for the 
ROI was selected by eye as the time when the intensity began to decline irreversibly.  If 
such a point could not be determined, the ROI was discarded.  The x,y location of each 
ROI was recorded and the linear distances were calculated from the ROI that had the first 
cytochrome c release.  (see Figure 40). 
 
Statistical Analysis 
All data were analyzed with excel software (Microsoft).  The analysis was 
performed using the Student‟s t-test. 
 
BAPTA-AM and Thapsigargin Experiments 
Media Changes: BAPTA-AM and Thapsigargin experiments required media 
changes during imaging. These experiments were performed in MatTek dishes, and 
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media exchange occurred via syringes connected to thin tubing inserted through the top 
of the MatTek dish.  
BAPTA-AM (1mM) (Alexis) and thapsigargin (5µM) (Sigma) were used to alter 
calcium signaling.  To reduce extracellular calcium levels, we added EGTA (1.2 mM) 
(Sigma) to CIM.  We conducted three different experiments.  The control experiment was 
the addition of TRAIL (1 μg/mL) to cells.  In these experiments EGTA and TRAIL were 
added to cells in CIM.   
The second experiment required the addition of BAPTA-AM (1mM) to quench 
cytosolic calcium. BAPTA-AM was not added at the beginning of the experiment.  
BAPTA-AM addition was delayed to minimize unintended consequences of the 1mM 
concentration.  Instead, TRAIL and EGTA were added to cells in CIM, and after the first 
cell released cytochrome c BAPTA-AM was added.  During the addition all media was 
removed from the MatTek dish, and replaced with fresh CIM, TRAIL, EGTA, and 
BAPTA-AM.  Analysis was conducted on cells that began to release cytochrome c at 
least 5 minutes after the addition of BAPTA-AM.  Control experiments showed that this 
is an appropriate time to ensure cytosolic calcium buffering.   
The third experiment involved adding thapsigargin to deplete the endoplasmic 
reticulum (ER) calcium.  Previous studies in HeLa cells indicated that Tg takes 
approximately 20 minutes to deplete ER calcium (Palmer et al., 2004).  Tg and EGTA 
were added to the CIM at the beginning of the experiment (prior to the addition of 
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TRAIL).  After 20 minutes the media was removed and replaced with CIM containing 
TRAIL, EGTA, and thapsigargin.   
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